METHOD FOR THE PRODUCTION OF GLYCEROL BY RECOMBINANT ORGANISMS

Abstract: Recombinant organisms are provided comprising genes encoding a glycerol-3-phosphate dehydrogenase and/or a glycerol-3-phosphatase activity useful for the production of glycerol from a variety of carbon substrates.

Description: TITLE METHOD FOR THE PRODUCTION OF GLYCEROL BY RECOMBINANT ORGANISMS FIELD OF INVENTION The present invention relates to the field of molecular biology and the use of recombinant organisms for the production of desired compounds. More specifically it describes the expression of cloned genes for glycerol-3-phosphate dehydrogenase (G3PDH) and glycerol-3-phosphatase (G3P phosphatase), either separately or together, for the enhanced production of glycerol. BACKGROUND Glycerol is a compound in great demand by industry for use in cosmetics, liquid soaps, food, pharmaceuticals, lubricants, anti-freeze solutions, and in numerous other applications. The esters of glycerol are important in the fat and oil industry. Not all organisms have a natural capacity to synthesize glycerol. However, the biological production of glycerol is known for some species of bacteria, algae, and yeasts. The bacteria Bacillus licheniformis and Lactobacillus lycopersica synthesize glycerol. Glycerol production is found in the halotolerant algae Dunaliella sp. and Asteromonas gracilis for protection against high external salt concentrations (Ben-Amotz et al., (1982) Experientia 38:49-52). Similarly, various osmotolerant yeasts synthesize glycerol as a protective measure. Most strains of Saccharomyces produce some glycerol during alcoholic fermentation, and this can be increased physiologically by the application of osmotic stress (Albertyn et al., (1994) Mol. Cell. Biol. 14, 4135-4144). Earlier this century glycerol was produced commercially with Saccharomyces cultures to which steering reagents were added such as sulfites or alkalis. Through the formation of an inactive complex, the steering agents block or inhibit the conversion of acetaldehyde to ethanol; thus, excess reducing equivalents (NADH) are available to or "steered" towards dihydroxyacetone phosphate (DHAP) for reduction to produce glycerol. This method is limited by the partial inhibition of yeast growth that is due to the sulfites. This limitation can be partially overcome by the use of alkalis which create excess NADH equivalents by a different mechanism. In this practice, the alkalis initiated a Cannizarro disproportionation to yield ethanol and acetic acid from two equivalents of acetaldehyde. The gene encoding glycerol-3 -phosphate dehydrogenase (D AR 1 ,GPD 1 ) has been cloned and sequenced from Saccharomyces diastaticus (Wang et al., (1994), J. Bad. 176:7091-7095). The DARl gene was cloned into a shuttle vector and used to transform E. coli where expression produced active enzyme. Wang et al., supra, recognizes that DARl is regulated by the cellular osmotic environment but does not suggest how the gene might be used to enhance glycerol production in a recombinant organism. Other glycerol-3 -phosphate dehydrogenase enzymes have been isolated. For example, sn-glycerol-3 -phosphate dehydrogenase has been cloned and sequenced from S. cerevisiae (Larason et al., (1993) Mol. Microbiol., 10:1101, (1993)). Albertyn et al., (1994) Mol. Cell. Biol, 14:4135) teach the cloning of GPD1 encoding a glycerol-3 -phosphate dehydrogenase from S. cerevisiae. Like Wang et al., both Albertyn et al., and Larason et al. recognize the osmo-sensitvity ofthe regulation of this gene but do not suggest how the gene might be used in the production of glycerol in a recombinant organism. As with G3DPH, glycerol-3-phosphatase has been isolated from Saccharomyces cerevisiae and the protein identified as being encoded by the GPP1 and GPP2 genes (Norbeck et al., (1996) J. Biol. Chem., 271:13875). Like the genes encoding G3DPH, it appears that GPP2 is osmotically-induced. There is no known art that teaches glycerol production from recombinant organisms with G3PDH/G3P phosphatase expressed together or separately. Nor is there known art that teaches glycerol production from any wild-type organism with these two enzyme activities that does not require applying some stress (salt or an osmolyte) to the cell. Eustace ((1987), Can. J. Microbiol., 33:112-117)) teaches away from achieving glycerol production by recombinant DNA techniques. By selective breeding techniques, these investigators created a hybridized yeast strain that produced glycerol at greater levels than the parent strains; however, the G3PDH activity remained constant or slightly lower. A microorganism capable of producing glycerol under physiological conditions is industrially desirable, especially when the glycerol itself will be used as a substrate in vivo as part of a more complex catabolic or biosynthetic pathway that could be perturbed by osmotic stress or the addition of steering agents. The problem to be solved, therefore, is how to direct carbon flux towards glycerol production by the addition or enhancement of certain enzyme activities, especially G3PDH and G3P phosphatase which respectively catalyze the conversion of dihydroxyacetone phosphate (DHAP) to glycerol-3-phosphate (G3P) and then to glycerol. This process has not previously been described for a recombinant organism and required the isolation of genes encoding the two enzymes and their subsequent expression. A surprising and unanticipated difficulty encountered was the toxicity of G3P phosphatase to the host which required careful control of its expression levels to avoid growth inhibition. SUMMARY OF THE INVENTION The present invention provides a method for the production of glycerol from a recombinant organism comprising: (i) transforming a suitable host cell with an expression cassette comprising either or both (a) a gene encoding a glycerol-3 -phosphate dehydrogenase enzyme; (b) a gene encoding a glycerol-3 -phosphate phosphatase enzyme; (ii) culturing the transformed host cell in the presence of at least one carbon source selected from the group consisting of monosaccharides, oligosaccharides, polysaccharides, and single-carbon substrates, or mixtures thereof whereby glycerol is produced; and (iii) recovering the glycerol. Glucose is the most preferred carbon source. The invention further provides transformed host cells comprising expression cassettes capable of expressing glycerol-3 -phosphate dehydrogenase and glycerol-3 -phosphatase activities for the production of glycerol. BRIEF DESCRIPTION OF BIOLOGICAL DEPOSITS AND SEQUENCE LISTING Applicants have made the following biological deposits under the terms of the Budapest Treaty on the International Recognition ofthe Deposit of Micro-organisms for the Purposes of Patent Procedure: Depositor Identification Int'l. Depository Reference Designation Date of Deposit Escherichia coli pAH21/DH5α ATCC 98187 26 September 1996 (containing the GPP2 gene) Escherichia coli (pDARl A/AA200) ATCC 98248 6 November 1996 (containing the DARl gene) "ATCC" refers to the American Type Culture Collection international depository located at 12301 Parklawn Drive, Rockville, MD 20852 U.S.A. The designation is the accession number ofthe deposited material. Applicants have provided 23 sequences in conformity with the Rules for the Standard Representation of Nucleotide and Amino Acid Sequences in Patent Applications (Annexes I and II to the Decision ofthe President ofthe EPO, published in Supplement No. 2 to OJ EPO, 12/1992) and with 37 C.F.R. 1.821-1.825 and Appendices A and B (Requirements for Application Disclosures Containing Nucleotides and/or Amino Acid Sequences). DETAILED DESCRIPTION OF THE INVENTION The present invention provides a method for the biological production of glycerol from a fermentable carbon source in a recombinant organism. The method provides a rapid, inexpensive and environmentally-responsible source of glycerol useful in the cosmetics and pharmaceutical industries. The method uses a microorganism containing cloned homologous or heterologous genes encoding glycerol-3 -phosphate dehydrogenase (G3PDH) and/or glycerol-3 -phosphatase (G3P phosphatase). The microorganism is contacted with a carbon source and glycerol is isolated from the conditioned media. The genes may be incorporated into the host microorganism separately or together for the production of glycerol. As used herein the following terms may be used for interpretation ofthe claims and specification. The terms "glycerol-3 -phosphate dehydrogenase" and "G3PDH" refer to a polypeptide responsible for an enzyme activity that catalyzes the conversion of dihydroxyacetone phosphate (DHAP) to glycerol-3-phosphate (G3P). In vivo G3PDH may be NADH; NADPH; or FAD-dependent. The NADH-dependent enzyme (EC 1.1.1.8) is encoded by several genes including GPD1 (GenBank Z74071x2), or GPD2 (GenBank Z35169x1), or GPD3 (GenBank G984182), or DARl (GenBank Z74071x2). The NADPH-dependent enzyme (EC 1.1.1.94) is encoded by gpsA (GenBank U321643, (cds 197911-196892) G466746 and L45246). The FAD-dependent enzyme (EC 1.1.99.5) is encoded by GUT2 (GenBank Z47047x23), or glpD (GenBank G147838), or glpABC (GenBank M20938). The terms "glycerol-3 -phosphatase", "sn-glycerol-3-phosphatase", or "d,l-glycerol phosphatase", and "G3P phosphatase" refer to a polypeptide responsible for an enzyme activity that catalyzes the conversion of glycerol-3- phosphate to glycerol. G3P phosphatase is encoded by GPP1 (GenBank Z47047xl25), or GPP2 (GenBank U18813xl l). The term "glycerol kinase" refers to a polypeptide responsible for an enzyme activity that catalyzes the conversion of glycerol to glycerol-3 -phosphate, or glycerol-3 -phosphate to glycerol, depending on reaction conditions. Glycerol kinase is encoded by GUT1 (GenBank UI 1583x19). The terms "GPD1", "DARl", "OSG1", "D2830". and "YDL022W" will be used interchangeably and refer to a gene that encodes a cytosolic glycerol-3 - phosphate dehydrogenase and is characterized by the base sequence given as SEQ ID NO: 1. The term "GPD2" refers to a gene that encodes a cytosolic glycerol-3 - phosphate dehydrogenase and is characterized by the base sequence given in SEQ ID NO:2. The terms "GUT2" and "YIL155C" are used interchangeably and refer to a gene that encodes a mitochondrial glycerol-3 -phosphate dehydrogenase and is characterized by the base sequence given in SEQ ID NO:3. The terms "GPP1", "RHR2" and "YIL053W" are used interchangeably and refer to a gene that encodes a cytosolic glycerol-3-phosphatase and is characterized by the base sequence given in SEQ ID NO:4. The terms "GPP2", "HOR2" and "YER062C" are used interchangeably and refer to a gene that encodes a cytosolic glycerol-3 -phosphatase and is characterized by the base sequence given as SEQ ID NO:5. The term "GUT1" refers to a gene that encodes a cytosolic glycerol kinase and is characterized by the base sequence given as SEQ ID NO:6. As used herein, the terms "function" and "enzyme function" refer to the catalytic activity of an enzyme in altering the energy required to perform a specific chemical reaction. Such an activity may apply to a reaction in equilibrium where the production of both product and substrate may be accomplished under suitable conditions. The terms "polypeptide" and "protein" are used herein interchangeably. The terms "carbon substrate" and "carbon source" refer to a carbon source capable of being metabolized by host organisms ofthe present invention and particularly mean carbon sources selected from the group consisting of mono- saccharides, oligosaccharides, polysaccharides, and one-carbon substrates or mixtures thereof. The terms "host cell" and "host organism" refer to a microorganism capable of receiving foreign or heterologous genes and expressing those genes to produce an active gene product. The terms "foreign gene", "foreign DNA", "heterologous gene", and "heterologous DNA" all refer to genetic material native to one organism that has been placed within a different host organism. The terms "recombinant organism" and "transformed host" refer to any organism transformed with heterologous or foreign genes. The recombinant organisms ofthe present invention express foreign genes encoding G3PDH and G3P phosphatase for the production of glycerol from suitable carbon substrates. "Gene" refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences preceding (5' non-coding) and following (3' non- coding) the coding region. The terms "native" and "wild-type" gene refer to the gene as found in nature with its own regulatory sequences. As used herein, the terms "encoding" and "coding" refer to the process by which a gene, through the mechanisms of transcription and translation, produces an amino acid sequence. The process of encoding a specific amino acid sequence is meant to include DNA sequences that may involve base changes that do not cause a change in the encoded amino acid, or which involve base changes which may alter one or more amino acids, but do not affect the functional properties of the protein encoded by the DNA sequence. Therefore, the invention encompasses more than the specific exemplary sequences. Modifications to the sequence, such as deletions, insertions, or substitutions in the sequence which produce silent changes that do not substantially affect the functional properties ofthe resulting protein molecule are also contemplated. For example, alterations in the gene sequence which reflect the degeneracy ofthe genetic code, or which result in the production of a chemically equivalent amino acid at a given site, are contemplated; thus, a codon for the amino acid alanine, a hydrophobic amino acid, may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine, or isoleucine. Similarly, changes which result in substitution of one negatively charged residue for another, such as aspartic acid for glutamic acid, or one positively charged residue for another, such as lysine for arginine, can also be expected to produce a biologically equivalent product. Nucleotide changes which result in alteration of the N-terminal and C-terminal portions ofthe protein molecule would also not be expected to alter the activity ofthe protein. In some cases, it may in fact be desirable to make mutants ofthe sequence in order to study the effect of alteration on the biological activity ofthe protein. Each ofthe proposed modifications is well within the routine skill in the art, as is determination of retention of biological activity in the encoded products. Moreover, the skilled artisan recognizes that sequences encompassed by this invention are also defined by their ability to hybridize, under stringent conditions (0.1X SSC, 0.1% SDS, 65 °C), with the sequences exemplified herein. The term "expression" refers to the transcription and translation to gene product from a gene coding for the sequence ofthe gene product. The terms "plasmid", "vector", and "cassette" as used herein refer to an extra chromosomal element often carrying genes which are not part ofthe central metabolism ofthe cell and usually in the form of circular double-stranded DNA molecules. Such elements may be autonomously replicating sequences, genome integrating sequences, phage or nucleotide sequences, linear or circular, of a single- or double-stranded DNA or RNA, derived from any source, in which a number of nucleotide sequences have been joined or recombined into a unique construction which is capable of introducing a promoter fragment and DNA sequence for a selected gene product along with appropriate 3' untranslated sequence into a cell. "Transformation cassette" refers to a specific vector containing a foreign gene and having elements in addition to the foreign gene that facilitate transformation of a particular host cell. "Expression cassette" refers to a specific vector containing a foreign gene and having elements in addition to the foreign gene that allow for enhanced expression of that gene in a foreign host. The terms "transformation" and "transfection" refer to the acquisition of new genes in a cell after the incorporation of nucleic acid. The acquired genes may be integrated into chromosomal DNA or introduced as extrachromosomal replicating sequences. The term "transformant" refers to the cell resulting from a transformation. The term "genetically altered" refers to the process of changing hereditary material by transformation or mutation. Representative enzyme pathway It is contemplated that glycerol may be produced in recombinant organisms by the manipulation ofthe glycerol biosynthetic pathway found in most microorganisms. Typically, a carbon substrate such as glucose is converted to glucose-6-phosphate via hexokinase in the presence of ATP. Glucose-phosphate isomerase catalyzes the conversion of glucose-6-phosphate to fructose-6- phosphate and then to fructose- 1 ,6-diphosphate through the action of 6-phosphofructokinase. The diphosphate is then taken to dihydroxyacetone phosphate (DHAP) via aldolase. Finally NADH-dependent G3PDH converts DHAP to glycerol-3-phosphate which is then dephosphorylated to glycerol by G3P phosphatase. (Agarwal (1990), Adv. Biochem. Engrg. 41 :114). Alternate pathways for glycerol production An alternative pathway for glycerol production from DHAP has been suggested (Wang et al., (1994) J. Bad. 176:7091-7095). In this proposed pathway DHAP could be dephosphorylated by a specific or non-specific phosphatase to give dihydroxyacetone, which could then be reduced to glycerol by a dihydroxyacetone reductase. Dihydroxyacetone reductase is known in prokaryotes and in Schizosaccharomycespom.be, and cloning and expression of such activities together with an appropriate phosphatase could lead to glycerol production. Another alternative pathway for glycerol production from DHAP has been suggested (Redkar ( 1995), Experimental Mycology, 19:241, 1995). In this pathway DHAP is isomerized to glyceraldehyde-3-phosphate by the common glycolytic enzyme triose phosphate isomerase. Glyceraldehyde-3 -phosphate is dephosphorylated to glyceraldehyde, which is then reduced by alcohol dehydrogenase or a NADP-dependent glycerol dehydrogenase activity. The cloning and expression ofthe phosphatase and dehydrogenase activities from Aspergillus nidulans could lead to glycerol production. Genes encoding G3PDH and G3P phosphatase The present invention provides genes suitable for the expression of G3PDH and G3P phosphatase activities in a host cell. Genes encoding G3PDH are known. For example, GPD1 has been isolated from Saccharomyces and has the base sequence given by SEQ ID NO: 1 , encoding the amino acid sequence given in SEQ ID NO:7 (Wang et al., supra). Similarly, G3PDH activity has also been isolated from Saccharomyces encoded by GPD2 having the base sequence given in SEQ ID NO:2 encoding the amino acid sequence given in SEQ ID NO:8 (Eriksson et al., (1995) Mol. Microbiol., 17:95). For the purposes ofthe present invention it is contemplated that any gene encoding a polypeptide responsible for G3PDH activity is suitable wherein that activity is capable of catalyzing the conversion of dihydroxyacetone phosphate (DHAP) to glycerol-3 -phosphate (G3P). Further, it is contemplated that any gene encoding the amino acid sequence of G3PDH as given by SEQ ID NOS:7, 8, 9, 10, 11 and 12 corresponding to the genes GPD1, GPD2, GUT2, gpsA, glpD, and the α subunit of glpABC respectively, will be functional in the present invention wherein that amino acid sequence may encompass amino acid substitutions, deletions or additions that do not alter the function ofthe enzyme. The skilled person will appreciate that genes encoding G3PDH isolated from other sources will also be suitable for use in the present invention. For example, genes isolated from prokaryotes include GenBank accessions M34393, M20938, L06231, U12567, L45246, L45323, L45324, L45325, U32164, U32689, and U39682. Genes isolated from fungi include GenBank accessions U30625, U30876 and X56162; genes isolated from insects include GenBank accessions X61223 and X14179; and genes isolated from mammalian sources include GenBank accessions U12424, M25558 and X78593. Genes encoding G3P phosphatase are known. For example, GPP2 has been isolated from Saccharomyces cerevisiae and has the base sequence given by SEQ ID NO:5, which encodes the amino acid sequence given in SEQ ID NO: 13 (Norbeck et al., (1996), J. Biol. Chem., 271:13875). For the purposes ofthe present invention, any gene encoding a G3P phosphatase activity is suitable for use in the method wherein that activity is capable of catalyzing the conversion of glycerol-3 -phosphate to glycerol. Further, any gene encoding the amino acid sequence of G3P phosphatase as given by SEQ ID NOS: 13 and 14 corresponding to the genes GPP2 and GPP1 respectively, will be functional in the present invention including any amino acid sequence that encompasses amino acid substitutions, deletions or additions that do not alter the function ofthe G3P phosphatase enzyme. The skilled person will appreciate that genes encoding G3P phosphatase isolated from other sources will also be suitable for use in the present invention. For example, the dephosphorylation of glycerol- 3-phosphate to yield glycerol may be achieved with one or more ofthe following general or specific phosphatases: alkaline phosphatase (EC 3.1.3.1) [GenBank M19159, M29663, U02550 or M33965]; acid phosphatase (EC 3.1.3.2) [GenBank U51210, U19789, U28658 or L20566]; glycerol-3 -phosphatase (EC 3.1.3.-) [GenBank Z38060 or U18813xl l]; glucose- 1 -phosphatase (EC 3.1.3.10) [GenBank M33807]; glucose-6-phosphatase (EC 3.1.3.9) [GenBank U00445]; fructose- 1 ,6-bisphosρhatase (EC 3.1.3.11) [GenBank XI 2545 or J03207] or phosphotidyl glycero phosphate phosphatase (EC 3.1.3.27) [GenBank M23546 and M23628]. Genes encoding glycerol kinase are known. For example, GUT1 encoding the glycerol kinase from Saccharomyces has been isolated and sequenced (Pavlik et al. (1993), Curr. Genet., 24:21) and the base sequence is given by SEQ ID NO:6, which encodes the amino acid sequence given in SEQ ID NO: 15. The skilled artisan will appreciate that, although glycerol kinase catalyzes the degradation of glycerol in nature, the same enzyme will be able to function in the synthesis of glycerol, converting glycerol-3 -phosphate to glycerol under the appropriate reaction energy conditions. Evidence exists for glycerol production through a glycerol kinase. Under anaerobic or respiration-inhibited conditions, Trypanosoma brucei gives rise to glycerol in the presence of Glycerol-3 -P and ADP. The reaction occurs in the glycosome compartment (Hammond, (1985), J. Biol. Chem., 260:15646-15654). Host cells Suitable host cells for the recombinant production of glycerol by the expression of G3PDH and G3P phosphatase may be either prokaryotic or eukaryotic and will be limited only by their ability to express active enzymes. Preferred host cells will be those bacteria, yeasts, and filamentous fungi typically useful for the production of glycerol such as Citrobader, Enterobacter, Clostridium, Klebsiella, Aerobader, Ladobacillus, Aspergillus, Saccharomyces. Schizosaccharomyces, Zygosaccharomyces, Pichia, Kluyveromyces, Candida, Hansenula, Debaryomyces, Mucor, Torulopsis, Methylobader , Escherichia, Salmonella, Bacillus, Streptomyces and Pseudomonas. Preferred in the present invention are E. coli and Saccharomyces. Vectors and expression cassettes The present invention provides a variety of vectors and transformation and expression cassettes suitable for the cloning, transformation and expression of G3PDH and G3P phosphatase into a suitable host cell. Suitable vectors will be those which are compatible with the bacterium employed. Suitable vectors can be derived, for example, from a bacteria, a virus (such as bacteriophage T7 or a M- 13 derived phage), a cosmid, a yeast or a plant. Protocols for obtaining and using such vectors are known to those in the art (Sambrook et al., Molecular Cloning: A Laboratory Manual - volumes 1, 2, 3 (Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1989)). Typically, the vector or cassette contains sequences directing transcription and translation ofthe appropriate gene, a selectable marker, and sequences allowing autonomous replication or chromosomal integration. Suitable vectors comprise a region 5' ofthe gene which harbors transcriptional initiation controls and a region 3' ofthe DNA fragment which controls transcriptional termination. It is most preferred when both control regions are derived from genes homologous to the transformed host cell. Such control regions need not be derived from the genes native to the specific species chosen as a production host. Initiation control regions, or promoters, which are useful to drive expression ofthe G3PDH and G3P phosphatase genes in the desired host cell are numerous and familiar to those skilled in the art. Virtually any promoter capable of driving these genes is suitable for the present invention including but not limited to CYC1, HIS3, GAL1, GAL10, ADH1, PGK, PHO5, GAPDH, ADC1, TRP1, URA3, LEU2, ENO, and TPI (useful for expression in Saccharomyces); AOXl (useful for expression in Pichia); and lac, tφ, λP L , λP R , T7, tac, and trc, (useful for expression in E. coli). Termination control regions may also be derived from various genes native to the preferred hosts. Optionally, a termination site may be unnecessary; however, it is most preferred if included. For effective expression ofthe instant enzymes, DNA encoding the enzymes are linked operably through initiation codons to selected expression control regions such that expression results in the formation ofthe appropriate messenger RNA. Transformation of suitable hosts and expression of G3PDH and G3P phosphatase for the production of glycerol Once suitable cassettes are constructed they are used to transform appropriate host cells. Introduction ofthe cassette containing the genes encoding G3PDH and/or G3P phosphatase into the host cell may be accomplished by known procedures such as by transformation, e.g., using calcium-permeabilized cells, electroporation, or by transfection using a recombinant phage virus (Sambrook et al., supra). In the present invention AH21 and DARl cassettes were used to transform the E. coli DH5α as fully described in the GENERAL METHODS and EXAMPLES. Media and Carbon Substrates Fermentation media in the present invention must contain suitable carbon substrates. Suitable substrates may include but are not limited to monosaccharides such as glucose and fructose, oligosaccharides such as lactose or sucrose, polysaccharides such as starch or cellulose or mixtures thereof and unpurified mixtures from renewable feedstocks such as cheese whey permeate, corasteep liquor, sugar beet molasses, and barley malt. Additionally, the carbon substrate may also be one-carbon substrates such as carbon dioxide, or methanol for which metabolic conversion into key biochemical intermediates has been demonstrated. Glycerol production from single carbon sources (e.g., methanol, formaldehyde or formate) has been reported in methylotrophic yeasts (Yamada et al. (1989), Agric. Biol. Chem., 53(2):541-543) and in bacteria (Hunter et al. (1985), Biochemistry, 24:4148-4155). These organisms can assimilate single carbon compounds, ranging in oxidation state from methane to formate, and produce glycerol. The pathway of carbon assimilation can be through ribulose monophosphate, through serine, or through xylulose-monophosphate (Gottschalk, Bacterial Metabolism, Second Edition, Springer-Verlag: New York (1986)). The ribulose monophosphate pathway involves the condensation of formate with ribulose-5-phosphate to form a 6 carbon sugar that becomes fructose and eventually the three carbon product, glyceraldehyde-3-phosphate. Likewise, the serine pathway assimilates the one-carbon compound into the glycolytic pathway via methylenetetrahydrofolate. In addition to one and two carbon substrates, methylotrophic organisms are also known to utilize a number of other carbon-containing compounds such as methylamine, glucosamine and a variety of amino acids for metabolic activity. For example, methylotrophic yeast are known to utilize the carbon from methylamine to form trehalose or glycerol (Bellion et al. (1993), Microb. Growth Cl Compd., [Int. Symp.], 7th, 415-32. Editor(s): Murrell, J. Collin; Kelly, Don P. Publisher: Intercept, Andover, UK). Similarly, various species of Candida will metabolize alanine or oleic acid (Suiter et al. (1990), Arch. Microbiol, 153(5):485-9). Hence, the source of carbon utilized in the present invention may encompass a wide variety of carbon-containing substrates and will only be limited by the choice of organism. Although all ofthe above mentioned carbon substrates and mixtures thereof are suitable in the present invention, preferred carbon substrates are monosaccharides, oligosaccharides, polysaccharides, single-carbon substrates or mixtures thereof. More preferred are sugars such as glucose, fructose, sucrose, maltose, lactose and single carbon substrates such as methanol and carbon dioxide. Most preferred as a carbon substrate is glucose. In addition to an appropriate carbon source, fermentation media must contain suitable minerals, salts, cofactors, buffers and other components, known to those skilled in the art, suitable for the growth ofthe cultures and promotion ofthe enzymatic pathway necessary for glycerol production. Culture Conditions Typically cells are grown at 30 °C in appropriate media. Preferred growth media are common commercially prepared media such as Luria Bertani (LB) broth, Sabouraud Dextrose (SD) broth, or Yeast medium (YM) broth. Other defined or synthetic growth media may also be used and the appropriate medium for growth ofthe particular microorganism will be known by one skilled in the art of microbiology or fermentation science. The use of agents known to modulate catabolite repression directly or indirectly, e.g., cyclic adenosine 2':3'-mono- phosphate, may also be incoφorated into the reaction media. Similarly, the use of agents known to modulate enzymatic activities (e.g., sulfites, bisulfites, and alkalis) that lead to enhancement of glycerol production may be used in conjunction with or as an alternative to genetic manipulations. Suitable pH ranges for the fermentation are between pH 5.0 to pH 9.0 where the range of pH 6.0 to pH 8.0 is preferred for the initial condition. Reactions may be performed under aerobic or anaerobic conditions where anaerobic or microaerobic conditions are preferred. Identification and purification of G3PDH and G3P phosphatase The levels of expression ofthe proteins G3PDH and G3P phosphatase are measured by enzyme assays. G3PDH activity assay relies on the spectral properties ofthe cosubstrate, NADH, in the DHAP conversion to G-3-P. NADH has intrinsic UV/vis absoφtion and its consumption can be monitored spectro- photometrically at 340 nm. G3P phosphatase activity can be measured by any method of measuring the inorganic phosphate liberated in the reaction. The most commonly used detection method uses the visible spectroscopic determination of a blue-colored phosphomolybdate ammonium complex. Identification and recovery of glycerol Glycerol may be identified and quantified by high performance liquid chromatography (HPLC) and gas chromatography/mass spectroscopy (GC/MS) analyses on the cell-free extracts. Preferred is a method where the fermentation media are analyzed on an analytical ion exchange column using a mobile phase of 0.01N sulfuric acid in an isocratic fashion. Methods for the recovery of glycerol from fermentation media are known in the art. For example, glycerol can be obtained from cell media by subjecting the reaction mixture to the following sequence of steps: filtration; water removal; organic solvent extraction; and fractional distillation (U.S. Patent No. 2,986,495). Selection of transformants by complementation In the absence of a functional gpsA -encoded G3PDH, E coli cells are unable to synthesize G3P, a condition which leads to a block in membrane biosynthesis. Cells with such a block are auxotrophic, requiring that either glycerol or G3P be present in the culture media for synthesis of membrane phospholipids. A cloned heterologous wild-type gpsA gene is able to complement the chromosomal gpsA mutation to allow growth in media lacking glycerol or G3P (Wang, et al. (1994), J Bad. 176:7091-7095). Based on this complementation strategy, growth of gpsA -defective cells on glucose would only occur if they possessed a plasmid-encoded gpsA, allowing a selection based on synthesis of G3P from DHAP. Cells which lose the recombinant gpsA plasmid during culture would fail to synthesize G3P and cell growth would subsequently be inhibited. The complementing G3PDH activity can be expressed not only from gpsA, but also from other cloned genes expressing G3PDH activity such as GPD1, GPD2, GPD3, GUT2, glpD, and glpABC. These can be maintained in a g/wvi -defective E. coli strain such as BB20 (Cronan et al. (1974), J. Bad., 118:598), alleviating the need to use antibiotic selection and its prohibitive cost in large-scale fermentations. A related strategy can be used for expression and selection in osmoregulatory mutants of 5. cerevisiae (Larsson et al. (1993), Mol. Microbiol. 10:1101-1111). These osg 1 mutants are unable to grow at low water potential and show a decreased capacity for glycerol production and reduced G3PDH activity. The osgl salt sensitivity defect can be complemented by a cloned and expressed G3PDH gene. Thus, the ability to synthesize glycerol can be used simultaneously as a selection marker for the desired glycerol-producing cells. EXAMPLES GENERAL METHODS Procedures for phosphorylations, ligations, and transformations are well known in the art. Techniques suitable for use in the following examples may be found in Sambrook et al., Molecular Cloning: A Laboratory Manual. Second Edition, Cold Spring Harbor Laboratory Press (1989). Materials and methods suitable for the maintenance and growth of bacterial cultures are well known in the art. Techniques suitable for use in the following examples may be found in Manual of Methods for General Bacteriology (Phillipp Gerhardt, R. G. E. Murray, Ralph N. Costilow, Eugene W. Nester, Willis A. Wood, Noel R. Krieg and G. Briggs Phillips, eds), American Society for Microbiology, Washington, DC. (1994) or in Biotechnology: A Textbook of Industrial Microbiology (Thomas D. Brock, Second Edition (1989) Sinauer Associates, Inc., Sunderland, MA). All reagents and materials used for the growth and maintenance of bacterial cells were obtained from Aldrich Chemicals (Milwaukee, WI), DIFCO Laboratories (Detroit, MI), GIBCO/BRL (Gaithersburg, MD), or Sigma Chemical Company (St. Louis, MO) unless otherwise specified. The meaning of abbreviations is as follows: "h" means hour(s), "min" means minute(s), "sec" means second(s), "d" means day(s), "mL" means milliliters, "L" means liters. Cell strains The following Escherichia coli strains were used for transformation and expression of G3PDH and G3P phosphatase. Strains were obtained from the E. coli Genetic Stock Center or from Life Technologies, Gaithersburg, MD). AA200 (garB10 uA22 ompF627 fadL701 relAl pit- 10 spoTl tpi-1 phoMSlO mcrBl) (Anderson et al., (1970), J. Gen. Microbiol, 62:329). BB20 (tonA22 ΔphoA8fadL701 relAl glpR2 glpD3 pit-10 gpsA20 spoTl T2R) (Cronan et al., J. Bad., 118:598). DH5 (deoR endAl gyrA96 hsdRl 7 recAl relAl supE44 thi-1 Δ(lacZYA- argFV169) phi80lacZΔMl 5 F ~ ) (Woodcock et al, (1989), Nucl Acids Res., 17:3469). Identification of Glycerol The conversion of glucose to glycerol was monitored by HPLC and/or GC. Analyses were performed using standard techniques and materials available to one of skill in the art of chromatography. One suitable method utilized a Waters Maxima 820 HPLC system using UV (210 nm) and RI detection. Samples were injected onto a Shodex SH-1011 column (8 mm x 300 mm; Waters, Milford, MA) equipped with a Shodex SH-101 IP precolumn (6 mm x 50 mm), temperature- controlled at 50 °C, using 0.01 N H2SO 4 as mobile phase at a flow rate of 0.5 mL/min. When quantitative analysis was desired, samples were injected onto a Shodex SH-1011 column (8 mm x 300 mm; Waters, Milford, MA) equipped with a Shodex SH-101 IP precolumn (6 mm x 50 mm), temperature-controlled at 50 °C, using 0.01 N H 2 SO 4 as mobile phase at a flow rate of 0.69 mL/min. When quantitative analysis was desired, samples were prepared with a known amount of trimethylacetic acid as an external standard. Typically, the retention times of glycerol (RI detection) and glucose (RI detection) were 17.03 min and 12.66 min, respectively. Glycerol was also analyzed by GC/MS. Gas chromatography with mass spectrometry detection for and quantitation of glycerol was done using a DB-WAX column (30 m, 0.32 mm I.D., 0.25 urn film thickness, j & W Scientific, Folsom, CA), at the following conditions: injector: split, 1 :15; sample volume: 1 uL; temperature profile: 150 °C intitial temperature with 30 sec hold, 40 °C/min to 180 °C, 20 °C/min to 240 °C, hold for 2.5 min. Detection: ΕI Mass Spectrometry (Hewlett Packard 5971, San Fernando, CA), quantitative SIM using ions 61 m/z and 64 m/z as target ions for glycerol and glycerol-d8, and ion 43 m/z as qualifier ion for glycerol. Glycerol-d8 was used as an internal standard. Assay for glvcerol-3-phosphatase, GPP The assay for enzyme activity was performed by incubating the extract with an organic phosphate substrate in a bis-Tris or MES and magnesium buffer, pH 6.5. The substrate used was either 1-α-glycerol phosphate, or d,l-α-glycerol phosphate. The final concentrations ofthe reagents in the assay are: buffer (20 mM, bis-Tris or 50 mM MES); MgCl 2 (10 mM); and substrate (20 mM). If the total protein in the sample was low and no visible precipitation occurs with an acid quench, the sample was conveniently assayed in the cuvette. This method involved incubating an enzyme sample in a cuvette that contained 20 mM substrate (50 μL, 200 mM), 50 mM MES, 10 mM MgCl 2 , pH 6.5 buffer. The final phosphatase assay volume was 0.5 mL. The enzyme-containing sample was added to the reaction mixture; the contents ofthe cuvette were mixed and then the cuvette was placed in a circulating water bath at T = 37 °C for 5 to 120 min, the length of time depending on whether the phosphatase activity in the enzyme sample ranged from 2 to 0.02 U/mL. The enzymatic reaction was quenched by the addition ofthe acid molybdate reagent (0.4 mL). After the Fiske SubbaRow reagent (0.1 mL) and distilled water (1.5 mL) were added, the solution was mixed and allowed to develop. After 10 min, to allow full color development, the absorbance ofthe samples was read at 660 nm using a Cary 219 UV/Vis spectrophotometer. The amount of inorganic phosphate released was compared to a standard curve that was prepared by using a stock inorganic phosphate solution (0.65 mM) and preparing 6 standards with final inorganic phosphate concentrations ranging from 0.026 to 0.130 μmol/mL. Spectrophotometric Assay for Glycerol 3-Phosphate Dehydrogenase (G3PDH) Activity The following procedure was used as modified below from a method published by Bell et al. (1975), J. Biol. Chem., 250:7153-8. This method involved incubating an enzyme sample in a cuvette that contained 0.2 mM NADH; 2.0 mM Dihydroxyacetone phosphate (DHAP), and enzyme in 0.1 M Tris/HCl, pH 7.5 buffer with 5 mM DTT,in a total volume of 1.0 mL at 30 °C. The spectrophotometer was set to monitor absorbance changes at the fixed wavelength of 340 nm. The instrument was blanked on a cuvette containing buffer only. After the enzyme was added to the cuvette, an absorbance reading was taken. The first substrate, NADH (50 uL 4 mM NADH; absorbance should increase approx 1.25 AU), was added to determine the background rate. The rate should be followed for at least 3 min. The second substrate, DHAP (50 uL 40 mM DHAP), was then added and the absorbance change over time was monitored for at least 3 min to determine to determine the gross rate. G3PDH activity was defined by subtracting the background rate from the gross rate. PLASMID CONSTRUCTION AND STRAIN CONSTRUCTION Cloning and expression of glycerol 3 -phosphatase for increase of glycerol production in E. coli The Saccharomyces cerevisiae chromosomeV lamda clone 6592 ( Gene Bank, accession # U18813xl 1) was obtained from ATCC. The glycerol 3 -phosphate phosphatase (GPP2) gene was cloned by cloning from the lamda clone as target DNA using synthetic primers (SΕQ ID NO: 16 with SΕQ ID NO: 17) incoφorating an BamHI-RBS-Xbal site at the 5' end and a Smal site at the 3' end. The product was subcloned into pCR-Script (Stratagene, Madison, WI) at the Srfl site to generate the plasmids pAH15 containing GPP2. The plasmid pAH15 contains the GPP2 gene in the inactive orientation for expression from the lac promoter in pCR-Script SK+. The BamHI-Smal fragment from pAH15 containing the GPP2 gene was inserted into pBlueScriptll SK+ to generate plasmid pAH19. The pAH19 contains the GPP2 gene in the correct orientation for expression from the lac promoter. The Xbal-Pstl fragment from pAH19 containing the GPP2 gene was inserted into pPHOX2 to create plasmid pAH21. The pAH21/ DH5α is the expression plasmid. Plasmids for the over-expression of DARl in E. coli DARl was isolated by PCR cloning from genomic S. cerevisiae DNA using synthetic primers (SΕQ ID NO: 18 with SΕQ ID NO: 19). Successful PCR cloning places an Ncol site at the 5' end of DARl where the ATG within Ncol is the DARl initiator methionine. At the 3' end of DARl a BamHI site is introduced following the translation terminator. The PCR fragments were digested with Ncol + BamHI and cloned into the same sites within the expression plasmid pTrc99A (Pharmacia, Piscataway, NJ) to give pDARl A. In order to create a better ribosome binding site at the 5' end of DARl, an Spel-RBS-NcoI linker obtained by annealing synthetic primers (SΕQ ID NO:20 with SΕQ ID NO:21) was inserted into the Ncol site of pD ARIA to create pAH40. Plasmid pAH40 contains the new RBS and DARl gene in the correct orientation for expression from the trc promoter of pTrc99A (Pharmacia, Piscataway, NJ). The NcoI-BamHI fragement from pDARl A and an second set of Spel-RBS-NcoI linker obtained by annealing synthetic primers (SΕQ ID NO:22 with SΕQ ID NO:23) was inserted into the Spel-BamHI site of pBC-SK+ (Stratagene, Madison, WI) to create plasmid pAH42. The plasmid pAH42 contains a chloramphenicol resistant gene. Construction of expression cassettes for DARl and GPP2 Expression cassettes for DARl and GPP2 were assembled from the individual DARl and GPP2 subclones described above using standard molecular biology methods. The BamHI-Pstl fragment from pAH19 containing the ribosomal binding site (RBS) and GPP2 gene was inserted into pAH40 to create pAH43. The BamHI-Pstl fragment from pAH19 containing the RBS and GPP2 gene was inserted into pAH42 to create pAH45. The ribosome binding site at the 5' end of GPP2 was modified as follows. A BamHI-RBS-Spel linker, obtained by annealing synthetic primers GATCCAGGAAACAGA (SEQ ID NO:24) with CTAGTCTGTTTCCTG (SEQ ID NO:25) to the Xbal-Pstl fragment from pAH19 containing the GPP2 gene, was inserted into the BamHI-Pstl site of pAH40 to create pAH48. Plasmid pAH48 contains the DARl gene, the modified RBS, and the GPP2 gene in the correct orientation for expression from the trc promoter of pTrc99A (Pharmacia, Piscataway, NJ). Transformation of E. coli All the plasmids described here were transformed into E. coli DH5α using standard molecular biology techniques. The transformants were verified by its DNA RFLP pattern. EXAMPLE 1 PRODUCTION OF GLYCEROL FROM E. COLI TRANSFORMED WITH G3PDH GENE Media Synthetic media was used for anaerobic or aerobic production of glycerol using E. coli cells transformed with pDARlA. The media contained per liter 6.0 g Na 2 HPO 4 , 3.0 g KH 2 PO 4 , 1.0 g NH 4 C1, 0.5 g NaCl, 1 mL 20% MgSO 4 .7H 2 O, 8.0 g glucose, 40 mg casamino acids, 0.5 ml 1% thiamine hydrochloride, 100 mg ampicillin. Growth Conditions Strain AA200 harboring pDARl A or the pTrc99A vector was grown in aerobic conditions in 50 mL of media shaking at 250 φm in 250 mL flasks at 37 °C. At A 6 oo 0.2-0.3 isopropylthio-β-D-galactoside was added to a final concentration of 1 mM and incubation continued for 48 h. For anaerobic growth samples of induced cells were used to fill Falcon #2054 tubes which were capped and gently mixed by rotation at 37 °C for 48 h. Glycerol production was determined by HPLC analysis ofthe culture supernatants. Strain pDARlA/AA200 produced 0.38 g/L glycerol after 48 h under anaerobic conditions, and 0.48 g/L under aerobic conditions. EXAMPLE 2 PRODUCTION OF GLYCEROL FROM E. COLI TRANSFORMED WITH G3P PHOSPHATASE GENE TGPP2) Media Synthetic phoA media was used in shake flasks to demonstrate the increase of glyceol by GPP2 expression in E. coli. The phoA medium contained per liter: Amisoy, 12 g; ammonium sulfate, 0.62 g; MOPS, 10.5 g; Na-citrate, 1.2 g; NaOH (1 M), 10 mL; 1 M MgSO 4 , 12 mL; 100X trace elements, 12 mL; 50%) glucose, 10 mL; 1% thiamine, 10 mL; 100 mg/mL L-proline, 10 mL; 2.5 mM FeCl 3 , 5 mL; mixed phosphates buffer, 2 mL (5 mL 0.2 M NaH 2 PO 4 + 9 mL 0.2 M K 2 HPO 4 ), and pH to 7.0. The 100X traces elements for phoA medium /L contained: ZnSO 4 .7 H 2 O, 0.58 g; MnSO 4 .H 2 O, 0.34 g; CuSO 4 .5 H 2 O, 0.49 g; CoCl 2 .6 H 2 O, 0.47 g; H 3 BO 3 , 0.12 g, NaMoO 4 .2 H 2 O, 0.48 g. Shake Flasks Experiments The strains pAH2 l/DH5α (containing GPP2 gene) and pPHOX2/DH5α (control) were grown in 45 mL of media (phoA media, 50 ug/mL carbenicillin, and 1 ug/mL vitamin B 12 ) in a 250 mL shake flask at 37 °C. The cultures were grown under aerobic condition (250 φm shaking) for 24 h. Glycerol production was determined by HPLC analysis ofthe culture supernatant. pAH21/DH5α produced 0.2 g/L glycerol after 24 h. EXAMPLE 3 Production of glycerol from D-glucose using recombinant E. coli containing both GPP2 and DARl Growth for demonstration of increased glycerol production by E. coli DH5α-containing pAH43 proceeds aerobically at 37 °C in shake-flask cultures (erlenmeyer flasks, liquid volume l/5th of total volume). Cultures in minimal media/ 1% glucose shake-flasks are started by inoculation from overnight LB/1% glucose culture with antibiotic selection. Minimal media are: filter-sterilized defined media, final pH 6.8 (HC1), contained per liter: 12.6 g (NH 4 ) 2 SO 4 , 13.7 g K 2 HPO 4 , 0.2 g yeast extract (Difco), 1 g NaHCO 3 , 5 mg vitamin B 12 , 5 mL Modified Balch's Trace-Element Solution (the composition of which can be found in Methods for General and Molecular Bacteriology (P. Gerhardt et al., eds, p. 158, American Society for Microbiology, Washington, DC (1994)). The shake-flasks are incubated at 37 °C with vigorous shaking for overnight, after which they are sampled for GC analysis ofthe supernatant. The pAH43/DH5α showed glycerol production of 3.8 g/L after 24 h. EXAMPLE 4 Production of glycerol from D-glucose using recombinant E. coli containing Both GPP2 and DARl Example 4 illustrates the production of glucose from the recombinant E. coli DH5α/pAH48, containing both the GPP2 and DARl genes. The strain DH5a/pAH48 was constructed as described above in the GENERAL METHODS. Pre-Culture DH5α/pAH48 were pre-cultured for seeding into a fermentation run. Components and protocols for the pre-culture are listed below. Pre-Culture Media KH 2 PO 4 30.0 g L Citric acid 2.0 g/L MgSO 4 -7H 2 O 2.0 g/L 98% H 2 SO 4 2.0 mL/L Ferric ammonium citrate 0.3 g/L CaCl 2 -2H 2 O 0.2 g/L Yeast extract 5.0 g/L Trace metals 5.0 mL/L Glucose 10.0 g/L Carbenicillin 100.0 mg/L The above media components were mixed together and the pH adjusted to 6.8 with NH 4 OH. The media was then filter sterilized. Trace metals were used according to the following recipe: Citric acid, monohydrate 4.0 g/L MgSO 4 -7H 2 O 3.0 g/L MnSO4-H 2 O 0.5 g/L NaCl 1.0 g/L FeSO4-7H 2 O 0.1 g/L CoC12-6H 2 O 0.1 g/L CaCl 2 0.1 g/L ZnSO 4 -7H 2 O 0.1 g/L CuSO 4 -5 H 2 O 10 mg/L AlK(SO 4 ) 2 -12H 2 O 10 mg/L H 3 BO 3 10 mg/L Na 2 MoO 4 -2H 2 O 10 mg/L NiSO4-6H 2 O 10 mg/L Na 2 SeO 3 10 mg/L Na 2 WO 4 -2H 2 O 10 mg/L Cultures were started from seed culture inoculated from 50 μL frozen stock (15%) glycerol as cryoprotectant) to 600 mL medium in a 2-L Erlenmeyer flask. Cultures were grown at 30 °C in a shaker at 250 φm for approximately 12 h and then used to seed the fermenter. Fermentation growth Vessel 15-L stirred tank fermenter Medium KH 2 PO 4 6.8 g/L Citric acid 2.0 g/L MgSO 4 -7H 2 O 2.0 g/L 98% H 2 SO 4 2.0 mL/L Ferric ammonium citrate 0.3 g/L CaCl 2 -2H 2 O 0.2 g/L Mazu DF204 antifoam 1.0 mL/L The above components were sterilized together in the fermenter vessel. The pH was raised to 6.7 with NH 4 OH. Yeast extract (5 g/L) and trace metals solution (5 mL/L) were added aseptically from filter sterilized stock solutions. Glucose was added from 60% feed to give final concentration of 10 g/L. Carbenicillin was added at 100 mg/L. Volume after inoculation was 6 L. Environmental Conditions For Fermentation The temperature was controlled at 36 °C and the air flow rate was controlled at 6 standard liters per minute. Back pressure was controlled at 0.5 bar. The agitator was set at 350 φm. Aqueous ammonia was used to control pH at 6.7. The glucose feed (60% glucose monohydrate) rate was controlled to maintain excess glucose. Results The results ofthe fermentation run are given in Table 1. Table 1 EFT OD550 [Glucose] [Glycerol] Total Glucose Total Glycerol (hr) (AU) (g/L) (g/L) Fed (g) Produced (g) 0 0.8 9.3 25 6 4.7 4.0 2.0 49 14 8 5.4 0 3.6 71 25 10 6.7 0.0 4.7 116 33 12 7.4 2.1 7.0 157 49 14.2 10.4 0.3 10.0 230 70 16.2 18.1 9.7 15.5 259 106 18.2 12.4 14.5 305 20.2 11.8 17.4 17.7 353 119 22.2 11.0 12.6 382 24.2 10.8 6.5 26.6 404 178 26.2 10.9 6.8 442 28.2 10.4 10.3 31.5 463 216 30.2 10.2 13.1 30.4 493 213 32.2 10.1 8.1 28.2 512 196 34.2 10.2 3.5 33.4 530 223 36.2 10.1 5.8 548 38.2 9.8 5.1 36.1 512 233 SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (A) NAME: E. I. DU PONT DE NEMOURS AND COMPANY (B) STREET: 1007 MARKET STREET (C) CITY: WILMINGTON (D) STATE: DELAWARE (E) COUNTRY: U.S.A. (F) POSTAL CODE (ZIP) : 19898 (G) TELEPHONE: 302-892-8112 (H) TELEFAX: 302-773-0164 (I) TELEX: 6717325 (A) ADDRESSEE: GENENCOR INTERNATIONAL, INC. (B) STREET: 4 CAMBRIDGE PLACE 1870 SOUTH WINTON ROAD (C) CITY: ROCHESTER (D) STATE: NEW YORK (E) COUNTRY: U.S.A. (F) POSTAL CODE (ZIP) : 14618 (ii) TITLE OF INVENTION: METHOD FOR THE PRODUCTION OF GLYCEROL BY RECOMBINANT ORGANISMS (iii) NUMBER OF SEQUENCES: 25 (iv) COMPUTER READABLE FORM: (A) MEDIUM TYPE: DISKETTE, 3.5 INCH (B) COMPUTER: IBM PC COMPATIBLE (C) OPERATING SYSTEM: MICROSOFT WORD FOR WINDOWS 95 (D) SOFTWARE: MICROSOFT WORD VERSION 7.0A (v) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: (C) CLASSIFICATION: (vi) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: 60/03602 (B) FILING DATE: NOVEMBER 13, 1996 (C) CLASSIFICATION: (vii) ATTORNEY/AGENT INFORMATION: (A) NAME: FLOYD, LINDA AXAMETHY (B) REGISTRATION NUMBER: 33,692 (C) REFERENCE/DOCKET NUMBER: CR-9981-P1 (2) INFORMATION FOR SEQ ID NO:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1380 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: CTTTAATTTT CTTTTATCTT ACTCTCCTAC ATAAGACATC AAGAAACAAT TGTATATTGT 60 ACACCCCCCC CCTCCACAAA CACAAATATT GATAATATAA AGATGTCTGC TGCTGCTGAT 120 AGATTAAACT TAACTTCCGG CCACTTGAAT GCTGGTAGAA AGAGAAGTTC CTCTTCTGTT 180 TCTTTGAAGG CTGCCGAAAA GCCTTTCAAG GTTACTGTGA TTGGATCTGG TAACTGGGGT 240 ACTACTATTG CCAAGGTGGT TGCCGAAAAT TGTAAGGGAT ACCCAGAAGT TTTCGCTCCA 300 ATAGTACAAA TGTGGGTGTT CGAAGAAGAG ATCAATGGTG AAAAATTGAC TGAAATCATA 360 AATACTAGAC ATCAAAACGT GAAATACTTG CCTGGCATCA CTCTACCCGA CAATTTGGTT 420 GCTAATCCAG ACTTGATTGA TTCAGTCAAG GATGTCGACA TCATCGTTTT CAACATTCCA 480 CATCAATTTT TGCCCCGTAT CTGTAGCCAA TTGAAAGGTC ATGTTGATTC ACACGTCAGA 540 GCTATCTCCT GTCTAAAGGG TTTTGAAGTT GGTGCTAAAG GTGTCCAATT GCTATCCTCT 600 TACATCACTG AGGAACTAGG TATTCAATGT GGTGCTCTAT CTGGTGCTAA CATTGCCACC 660 GAAGTCGCTC AAGAACACTG GTCTGAAACA ACAGTTGCTT ACCACATTCC AAAGGATTTC 720 AGAGGCGAGG GCAAGGACGT CGACCATAAG GTTCTAAAGG CCTTGTTCCA CAGACCTTAC 780 TTCCACGTTA GTGTCATCGA AGATGTTGCT GGTATCTCCA TCTGTGGTGC TTTGAAGAAC 840 GTTGTTGCCT TAGGTTGTGG TTTCGTCGAA GGTCTAGGCT GGGGTAACAA CGCTTCTGCT 900 GCCATCCAAA GAGTCGGTTT GGGTGAGATC ATCAGATTCG GTCAAATGTT TTTCCCAGAA 960 TCTAGAGAAG AAACATACTA CCAAGAGTCT GCTGGTGTTG CTGATTTGAT CACCACCTGC 1020 GCTGGTGGTA GAAACGTCAA GGTTGCTAGG CTAATGGCTA CTTCTGGTAA GGACGCCTGG 1080 GAATGTGAAA AGGAGTTGTT GAATGGCCAA TCCGCTCAAG GTTTAATTAC CTGCAAAGAA 1140 GTTCACGAAT GGTTGGAAAC ATGTGGCTCT GTCGAAGACT TCCCATTATT TGAAGCCGTA 1200 TACCAAATCG TTTACAACAA CTACCCAATG AAGAACCTGC CGGACATGAT TGAAGAATTA 1260 GATCTACATG AAGATTAGAT TTATTGGAGA AAGATAACAT ATCATACTTC CCCCACTTTT 1320 TTCGAGGCTC TTCTATATCA TATTCATAAA TTAGCATTAT GTCATTTCTC ATAACTACTT 1380 (2) INFORMATION FOR SEQ ID NO : 2 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2946 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: GAATTCGAGC CTGAAGTGCT GATTACCTTC AGGTAGACTT CATCTTGACC CATCAACCCC 60 AGCGTCAATC CTGCAAATAC ACCACCCAGC AGCACTAGGA TGATAGAGAT AATATAGTAC 120 GTGGTAACGC TTGCCTCATC ACCTACGCTA TGGCCGGAAT CGGCAACATC CCTAGAATTG 180 AGTACGTGTG ATCCGGATAA CAACGGCAGT GAATATATCT TCGGTATCGT AAAGATGTGA 240 TATAAGATGA TGTATACCCA ATGAGGAGCG CCTGATCGTG ACCTAGACCT TAGTGGCAAA 300 AACGACATAT CTATTATAGT GGGGAGAGTT TCGTGCAAAT AACAGACGCA GCAGCAAGTA 360 ACTGTGACGA TATCAACTCT TTTTTTATTA TGTAATAAGC AAACAAGCAC GAATGGGGAA 420 AGCCTATGTG CAATCACCAA GGTCGTCCCT TTTTTCCCAT TTGCTAATTT AGAATTTAAA 480 GAAACCAAAA GAATGAAGAA AGAAAACAAA TACTAGCCCT AACCCTGACT TCGTTTCTAT 540 GATAATACCC TGCTTTAATG AACGGTATGC CCTAGGGTAT ATCTCACTCT GTACGTTACA 600 AACTCCGGTT ATTTTATCGG AACATCCGAG CACCCGCGCC TTCCTCAACC CAGGCACCGC 660 CCCAGGTAAC CGTGCGCGAT GAGCTAATCC TGAGCCATCA CCCACCCCAC CCGTTGATGA 720 CAGCAATTCG GGAGGGCGAA AATAAAACTG GAGCAAGGAA TTACCATCAC CGTCACCATC 780 ACCATCATAT CGCCTTAGCC TCTAGCCATA GCCATCATGC AAGCGTGTAT CTTCTAAGAT 840 TCAGTCATCA TCATTACCGA GTTTGTTTTC CTTCACATGA TGAAGAAGGT TTGAGTATGC 900 TCGAAACAAT AAGACGACGA TGGCTCTGCC ATTGGTTATA TTACGCTTTT GCGGCGAGGT 960 GCCGATGGGT TGCTGAGGGG AAGAGTGTTT AGCTTACGGA CCTATTGCCA TTGTTATTCC 1020 GATTAATCTA TTGTTCAGCA GCTCTTCTCT ACCCTGTCAT TCTAGTATTT TTTTTTTTTT 1080 TTTTTGGTTT TACTTTTTTT TCTTCTTGCC TTTTTTTCTT GTTACTTTTT TTCTAGTTTT 1140 TTTTCCTTCC ACTAAGCTTT TTCCTTGATT TATCCTTGGG TTCTTCTTTC TACTCCTTTA 1200 GATTTTTTTT TTATATATTA ATTTTTAAGT TTATGTATTT TGGTAGATTC AATTCTCTTT 1260 CCCTTTCCTT TTCCTTCGCT CCCCTTCCTT ATCAATGCTT GCTGTCAGAA GATTAACAAG 1320 ATACACATTC CTTAAGCGAA CGCATCCGGT GTTATATACT CGTCGTGCAT ATAAAATTTT 1380 GCCTTCAAGA TCTACTTTCC TAAGAAGATC ATTATTACAA ACACAACTGC ACTCAAAGAT 1440 GACTGCTCAT ACTAATATCA AACAGCACAA ACACTGTCAT GAGGACCATC CTATCAGAAG 1500 ATCGGACTCT GCCGTGTCAA TTGTACATTT GAAACGTGCG CCCTTCAAGG TTACAGTGAT 1560 TGGTTCTGGT AACTGGGGGA CCACCATCGC CAAAGTCATT GCGGAAAACA CAGAATTGCA 1620 TTCCCATATC TTCGAGCCAG AGGTGAGAAT GTGGGTTTTT GATGAAAAGA TCGGCGACGA 1680 AAATCTGACG GATATCATAA ATACAAGACA CCAGAACGTT AAATATCTAC CCAATATTGA 1740 CCTGCCCCAT AATCTAGTGG CCGATCCTGA TCTTTTACAC TCCATCAAGG GTGCTGACAT 1800 CCTTGTTTTC AACATCCCTC ATCAATTTTT ACCAAACATA GTCAAACAAT TGCAAGGCCA 1860 CGTGGCCCCT CATGTAAGGG CCATCTCGTG TCTAAAAGGG TTCGAGTTGG GCTCCAAGGG 1920 TGTGCAATTG CTATCCTCCT ATGTTACTGA TGAGTTAGGA ATCCAATGTG GCGCACTATC 1980 TGGTGCAAAC TTGGCACCGG AAGTGGCCAA GGAGCATTGG TCCGAAACCA CCGTGGCTTA 2040 CCAACTACCA AAGGATTATC AAGGTGATGG CAAGGATGTA GATCATAAGA TTTTGAAATT 2100 GCTGTTCCAC AGACCTTACT TCCACGTCAA TGTCATCGAT GATGTTGCTG GTATATCCAT 2160 TGCCGGTGCC TTGAAGAACG TCGTGGCACT TGCATGTGGT TTCGTAGAAG GTATGGGATG 2220 GGGTAACAAT GCCTCCGCAG CCATTCAAAG GCTGGGTTTA GGTGAAATTA TCAAGTTCGG 2280 TAGAATGTTT TTCCCAGAAT CCAAAGTCGA GACCTACTAT CAAGAATCCG CTGGTGTTGC 2340 AGATCTGATC ACCACCTGCT CAGGCGGTAG AAACGTCAAG GTTGCCACAT ACATGGCCAA 2400 GACCGGTAAG TCAGCCTTGG AAGCAGAAAA GGAATTGCTT AACGGTCAAT CCGCCCAAGG 2460 GATAATCACA TGCAGAGAAG TTCACGAGTG GCTACAAACA TGTGAGTTGA CCCAAGAATT 2520 CCCAATTATT CGAGGCAGTC TACCAGATAG TCTACAACAA CGTCCGCATG GAAGACCTAC 2580 CGGAGATGAT TGAAGAGCTA GACATCGATG ACGAATAGAC ACTCTCCCCC CCCCTCCCCC 2640 TCTGATCTTT CCTGTTGCCT CTTTTTCCCC CAACCAATTT ATCATTATAC ACAAGTTCTA 2700 CAACTACTAC TAGTAACATT ACTACAGTTA TTATAATTTT CTATTCTCTT TTTCTTTAAG 2760 AATCTATCAT TAACGTTAAT TTCTATATAT ACATAACTAC CATTATACAC GCTATTATCG 2820 TTTACATATC ACATCACCGT TAATGAAAGA TACGACACCC TGTACACTAA CACAATTAAA 2880 TAATCGCCAT AACCTTTTCT GTTATCTATA GCCCTTAAAG CTGTTTCTTC GAGCTTTTCA 2940 CTGCAG 2946 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3178 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (11) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 3 : CTGCAGAACT TCGTCTGCTC TGTGCCCATC CTCGCGGTTA GAAAGAAGCT GAATTGTTTC 60 ATGCGCAAGG GCATCAGCGA GTGACCAATA ATCACTGCAC TAATTCCTTT TTAGCAACAC 120 ATACTTATAT ACAGCACCAG ACCTTATGTC TTTTCTCTGC TCCGATACGT TATCCCACCC 180 AACTTTTATT TCAGTTTTGG CAGGGGAAAT TTCACAACCC CGCACGCTAA AAATCGTATT 240 TAAACTTAAA AGAGAACAGC CACAAATAGG GAACTTTGGT CTAAACGAAG GACTCTCCCT 300 CCCTTATCTT GACCGTGCTA TTGCCATCAC TGCTACAAGA CTAAATACGT ACTAATATAT 360 GTTTTCGGTA ACGAGAAGAA GAGCTGCCGG TGCAGCTGCT GCCATGGCCA CAGCCACGGG 420 GACGCTGTAC TGGATGACTA GCCAAGGTGA TAGGCCGTTA GTGCACAATG ACCCGAGCTA 480 CATGGTGCAA TTCCCCACCG CCGCTCCACC GGCAGGTCTC TAGACGAGAC CTGCTGGACC 540 GTCTGGACAA GACGCATCAA TTCGACGTGT TGATCATCGG TGGCGGGGCC ACGGGGACAG 600 GATGTGCCCT AGATGCTGCG ACCAGGGGAC TCAATGTGGC CCTTGTTGAA AAGGGGGATT 660 TTGCCTCGGG AACGTCGTCC AAATCTACCA AGATGATTCA CGGTGGGGTG CGGTACTTAG 720 AGAAGGCCTT CTGGGAGTTC TCCAAGGCAC AACTGGATCT GGTCATCGAG GCACTCAACG 780 AGCGTAAACA TCTTATCAAC ACTGCCCCTC ACCTGTGCAC GGTGCTACCA ATTCTGATCC 840 CCATCTACAG CACCTGGCAG GTCCCGTACA TCTATATGGG CTGTAAATTC TACGATTTCT 900 TTGGCGGTTC CCAAAACTTG AAAAAATCAT ACCTACTGTC CAAATCCGCC ACCGTGGAGA 960 AGGCTCCCAT GCTTACCACA GACAATTTAA AGGCCTCGCT TGTGTACCAT GATGGGTCCT 1020 TTAACGACTC GCGTTTGAAC GCCACTTTAG CCATCACGGG TGTGGAGAAC GGCGCTACCG 1080 TCTTGATCTA TGTCGAGGTA CAAAAATTGA TCAAAGACCC AACTTCTGGT AAGGTTATCG 1140 GTGCCGAGGC CCGGGACGTT GAGACTAATG AGCTTGTCAG AATCAACGCT AAATGTGTGG 1200 TCAATGCCAC GGGCCCATAC AGTGACGCCA TTTTGCAAAT GGACCGCAAC CCATCCGGTC 1260 TGCCGGACTC CCCGCTAAAC GACAACTCCA AGATCAAGTC GACTTTCAAT CAAATCTCCG 1320 TCATGGACCC GAAAATGGTC ATCCCATCTA TTGGCGTTCA CATCGTATTG CCCTCTTTTT 1380 ACTCCCCGAA GGATATGGGT TTGTTGGACG TCAGAACCTC TGATGGCAGA GTGATGTTCT 1440 TTTTACCTTG GCAGGGCAAA GTCCTTGCCG GCACCACAGA CATCCCACTA AAGCAAGTCC 1500 CAGAAAACCC TATGCCTACA GAGGCTGATA TTCAAGATAT CTTGAAAGAA CTACAGCACT 1560 ATATCGAATT CCCCGTGAAA AGAGAAGACG TGCTAAGTGC ATGGGCTGGT GTCAGACCTT 1620 TGGTCAGAGA TCCACGTACA ATCCCCGCAG ACGGGAAGAA GGGCTCTGCC ACTCAGGGCG 1680 TGGTAAGATC CCACTTCTTG TTCACTTCGG ATAATGGCCT AATTACTATT GCAGGTGGTA 1740 AATGGACTAC TTACAGACAA ATGGCTGAGG AAACAGTCGA CAAAGTTGTC GAAGTTGGCG 1800 GATTCCACAA CCTGAAACCT TGTCACACAA GAGATATTAA GCTTGCTGGT GCAGAAGAAT 1860 GGACGCAAAA CTATGTGGCT TTATTGGCTC AAAACTACCA TTTATCATCA AAAATGTCCA 1920 ACTACTTGGT TCAAAACTAC GGAACCCGTT CCTCTATCAT TTGCGAATTT TTCAAAGAAT 1980 CCATGGAAAA TAAACTGCCT TTGTCCTTAG CCGACAAGGA AAATAACGTA ATCTACTCTA 2040 GCGAGGAGAA CAACTTGGTC AATTTTGATA CTTTCAGATA TCCATTCACA ATCGGTGAGT 2100 TAAAGTATTC CATGCAGTAC GAATATTGTA GAACTCCCTT GGACTTCCTT TTAAGAAGAA 2160 CAAGATTCGC CTTCTTGGAC GCCAAGGAAG CTTTGAATGC CGTGCATGCC ACCGTCAAAG 2220 TTATGGGTGA TGAGTTCAAT TGGTCGGAGA AAAAGAGGCA GTGGGAACTT GAAAAAACTG 2280 TGAACTTCAT CCAAGGACGT TTCGGTGTCT AAATCGATCA TGATAGTTAA GGGTGACAAA 2340 GATAACATTC ACAAGAGTAA TAATAATGGT AATGATGATA ATAATAATAA TGATAGTAAT 2400 AACAATAATA ATAATGGTGG TAATGGCAAT GAAATCGCTA TTATTACCTA TTTTCCTTAA 2460 TGGAAGAGTT AAAGTAAACT AAAAAAACT CAAAAATATA TGAAGAAAAA AAAAAAAAGA 2520 GGTAATAGAC TCTACTACTA CAATTGATCT TCAAATTATG ACCTTCCTAG TGTTTATATT 2580 CTATTTCCAA TACATAATAT AATCTATATA ATCATTGCTG GTAGACTTCC GTTTTAATAT 2640 CGTTTTAATT ATCCCCTTTA TCTCTAGTCT AGTTTTATCA TAAAATATAG AAACACTAAA 2700 TAATATTCTT CAAACGGTCC TGGTGCATAC GCAATACATA TTTATGGTGC AAAAAAAAAA 2760 ATGGAAAATT TTGCTAGTCA TAAACCCTTT CATAAAACAA TACGTAGACA TCGCTACTTG 2820 AAATTTTCAA GTTTTTATCA GATCCATGTT TCCTATCTGC CTTGACAACC TCATCGTCGA 2880 AATAGTACCA TTTAGAACGC CCAATATTCA CATTGTGTTC AAGGTCTTTA TTCACCAGTG 2940 ACGTGTAATG GCCATGATTA ATGTGCCTGT ATGGTTAACC ACTCCAAATA GCTTATATTT 3000 CATAGTGTCA TTGTTTTTCA ATATAATGTT TAGTATCAAT GGATATGTTA CGACGGTGTT 3060 ATTTTTCTTG GTCAAATCGT AATAAAATCT CGATAAATGG ATGACTAAGA TTTTTGGTAA 3120 AGTTACAAAA TTTATCGTTT TCACTGTTGT CAATTTTTTG TTCTTGTAAT CACTCGAG 3178 (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 816 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 4 : ATGAAACGTT TCAATGTTTT AAAATATATC AGAACAACAA AAGCAAATAT ACAAACCATC 60 GCAATGCCTT TGACCACAAA ACCTTTATCT TTGAAAATCA ACGCCGCTCT ATTCGATGTT 120 GACGGTACCA TCATCATCTC TCAACCAGCC ATTGCTGCTT TCTGGAGAGA TTTCGGTAAA 180 GACAAGCCTT ACTTCGATGC CGAACACGTT ATTCACATCT CTCACGGTTG GAGAACTTAC 240 GATGCCATTG CCAAGTTCGC TCCAGACTTT GCTGATGAAG AATACGTTAA CAAGCTAGAA 300 GGTGAAATCC CAGAAAAGTA CGGTGAACAC TCCATCGAAG TTCCAGGTGC TGTCAAGTTG 360 TGTAATGCTT TGAACGCCTT GCCAAAGGAA AAATGGGCTG TCGCCACCTC TGGTACCCGT 420 GACATGGCCA AGAAATGGTT CGACATTTTG AAGATCAAGA GACCAGAATA CTTCATCACC 480 GCCAATGATG TCAAGCAAGG TAAGCCTCAC CCAGAACCAT ACTTAAAGGG TAGAAACGGT 540 TTGGGTTTCC CAATTAATGA ACAAGACCCA TCCAAATCTA AGGTTGTTGT CTTTGAAGAC 600 GCACCAGCTG GTATTGCTGC TGGTAAGGCT GCTGGCTGTA AAATCGTTGG TATTGCTACC 660 ACTTTCGATT TGGACTTCTT GAAGGAAAAG GGTTGTGACA TCATTGTCAA GAACCACGAA 720 TCTATCAGAG TCGGTGAATA CAACGCTGAA ACCGATGAAG TCGAATTGAT CTTTGATGAC 780 TACTTATACG CTAAGGATGA CTTGTTGAAA TGGTAA 816 (2) INFORMATION FOR SEQ ID NO: 5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 753 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5: ATGGGATTGA CTACTAAACC TCTATCTTTG AAAGTTAACG CCGCTTTGTT CGACGTCGAC 60 GGTACCATTA TCATCTCTCA ACCAGCCATT GCTGCATTCT GGAGGGATTT CGGTAAGGAC 120 AAACCTTATT TCGATGCTGA ACACGTTATC CAAGTCTCGC ATGGTTGGAG AACGTTTGAT 180 GCCATTGCTA AGTTCGCTCC AGACTTTGCC AATGAAGAGT ATGTTAACAA ATTAGAAGCT 240 GAAATTCCGG TCAAGTACGG TGAAAAATCC ATTGAAGTCC CAGGTGCAGT TAAGCTGTGC 300 AACGCTTTGA ACGCTCTACC AAAAGAGAAA TGGGCTGTGG CAACTTCCGG TACCCGTGAT 360 ATGGCACAAA AATGGTTCGA GCATCTGGGA ATCAGGAGAC CAAAGTACTT CATTACCGCT 420 AATGATGTCA AACAGGGTAA GCCTCATCCA GAACCATATC TGAAGGGCAG GAATGGCTTA 480 GGATATCCGA TCAATGAGCA AGACCCTTCC AAATCTAAGG TAGTAGTΛTT TGAAGACGCT 540 CCAGCAGGTA TTGCCGCCGG AAAAGCCGCC GGTTGTAAGA TCATTGGTAT TGCCACTACT 600 TTCGACTTGG ACTTCCTAAA GGAAAAAGGC TGTGACATCA TTGTCAAAAA CCACGAATCC 660 ATCAGAGTTG GCGGCTACAA TGCCGAAACA GACGAAGTTG AATTCATTTT TGACGACTAC 720 TTATATGCTA AGGACGATCT GTTGAAATGG TAA 753 (2) INFORMATION FOR SEQ ID NO: 6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2520 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: TGTATTGGCC ACGATAACCA CCCTTTGTAT ACTGTTTTTG TTTTTCACAT GGTAAATAAC 60 GACTTTTATT AAACAACGTA TGTAAAAACA TAACAAGAAT CTACCCATAC AGGCCATTTC 120 GTAATTCTTC TCTTCTAATT GGAGTAAAAC CATCAATTAA AGGGTGTGGA GTAGCATAGT 180 GAGGGGCTGA CTGCATTGAC AAAAAAATTG AAAAAAAAAA AGGAAAAGGA AAGGAAAAAA 240 AGACAGCCAA GACTTTTAGA ACGGATAAGG TGTAATAAAA TGTGGGGGGA TGCCTGTTCT 300 CGAACCATAT AAAATATACC ATGTGGTTTG AGTTGTGGCC GGAACTATAC AAATAGTTAT 360 ATGTTTCCCT CTCTCTTCCG ACTTGTAGTA TTCTCCAAAC GTTACATATT CCGATCAAGC 420 CAGCGCCTTT ACACTAGTTT AAAACAAGAA CAGAGCCGTA TGTCCAAAAT AATGGAAGAT 480 TTACGAAGTG ACTACGTCCC GCTTATCGCC AGTATTGATG TAGGAACGAC CTCATCCAGA 540 TGCATTCTGT TCAACAGATG GGGCCAGGAC GTTTCAAAAC ACCAAATTGA ATATTCAACT 600 TCAGCATCGA AGGGCAAGAT TGGGGTGTCT GGCCTAAGGA GACCCTCTAC AGCCCCAGCT 660 CGTGAAACAC CAAACGCCGG TGACATCAAA ACCAGCGGAA AGCCCATCTT TTCTGCAGAA 720 GGCTATGCCA TTCAAGAAAC CAAATTCCTA AAAATCGAGG AATTGGACTT GGACTTCCAT 780 AACGAACCCA CGTTGAAGTT CCCCAAACCG GGTTGGGTTG AGTGCCATCC GCAGAAATTA 840 CTGGTGAACG TCGTCCAATG CCTTGCCTCA AGTTTGCTCT CTCTGCAGAC TATCAACAGC 900 GAACGTGTAG CAAACGGTCT CCCACCTTAC AAGGTAATAT GCATGGGTAT AGCAAACATG 960 AGAGAAACCA CAATTCTGTG GTCCCGCCGC ACAGGAAAAC CAATTGTTAA CTACGGTATT 1020 GTTTGGAACG ACACCAGAAC GATCAAAATC GTTAGAGACA AATGGCAAAA CACTAGCGTC 1080 GATAGGCAAC TGCAGCTTAG ACAGAAGACT GGATTGCCAT TGCTCTCCAC GTATTTCTCC 1140 TGTTCCAAGC TGCGCTGGTT CCTCGACAAT GAGCCTCTGT GTACCAAGGC GTATGAGGAG 1200 AACGACCTGA TGTTCGGCAC TGTGGACACA TGGCTGATTT ACCAATTAAC TAAACAAAAG 1260 GCGTTCGTTT CTGACGTAAC CAACGCTTCC AGAACTGGAT TTATGAACCT CTCCACTTTA 1320 AAGTACGACA ACGAGTTGCT GGAATTTTGG GGTATTGACA AGAACCTGAT TCACATGCCC 1380 GAAATTGTGT CCTCATCTCA ATACTACGGT GACTTTGGCA TTCCTGATTG GATAATGGAA 1440 AAGCTACACG ATTCGCCAAA AACAGTACTG CGAGATCTAG TCAAGAGAAA CCTGCCCATA 1500 CAGGGCTGTC TGGGCGACCA AAGCGCATCC ATGGTGGGGC AACTCGCTTA CAAACCCGGT 1560 GCTGCAAAAT GTACTTATGG TACCGGTTGC TTTTTACTGT ACAATACGGG GACCAAAAAA 1620 TTGATCTCCC AACATGGCGC ACTGACGACT CTAGCATTTT GGTTCCCACA TTTGCAAGAG 1680 TACGGTGGCC AAAAACCAGA ATTGAGCAAG CCACATTTTG CATTAGAGGG TTCCGTCGCT 1740 GTGGCTGGTG CTGTGGTCCA ATGGCTACGT GATAATTTAC GATTGATCGA TAAATCAGAG 1800 GATGTCGGAC CGATTGCATC TACGGTTCCT GATTCTGGTG GCGTAGTTTT CGTCCCCGCA 1860 TTTAGTGGCC TATTCGCTCC CTATTGGGAC CCAGATGCCA GAGCCACCAT AATGGGGATG 1920 TCTCAATTCA CTACTGCCTC CCACATCGCC AGAGCTGCCG TGGAAGGTGT TTGCTTTCAA 1980 GCCAGGGCTA TCTTGAAGGC AATGAGTTCT GACGCGTTTG GTGAAGGTTC CAAAGACAGG 2040 GACTTTTTAG AGGAAATTTC CGACGTCACA TATGAAAAGT CGCCCCTGTC GGTTCTGGCA 2100 GTGGATGGCG GGATGTCGAG GTCTAATGAA GTCATGCAAA TTCAAGCCGA TATCCTAGGT 2160 CCCTGTGTCA AAGTCAGAAG GTCTCCGACA GCGGAATGTA CCGCATTGGG GGCAGCCATT 2220 GCAGCCAATA TGGCTTTCAA GGATGTGAAC GAGCGCCCAT TATGGAAGGA CCTACACGAT 2280 GTTAAGAAAT GGGTCTTTTA CAATGGAATG GAGAAAAACG AACAAATATC ACCAGAGGCT 2340 CATCCAAACC TTAAGATATT CAGAAGTGAA TCCGACGATG CTGAAAGGAG AAAGCATTGG 2400 AAGTATTGGG AAGTTGCCGT GGAAAGATCC AAAGGTTGGC TGAAGGACAT AGAAGGTGAA 2460 CACGAACAGG TTCTAGAAAA CTTCCAATAA CAACATAAAT AATTTCTATT AACAATGTAA 2520 (2) INFORMATION FOR SEQ ID NO: 7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 391 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7: Met Ser Ala Ala Ala Asp Arg Leu Asn Leu Thr Ser Gly His Leu Asn 1 5 10 15 Ala Gly Arg Lys Arg Ser Ser Ser Ser Val Ser Leu Lys Ala Ala Glu 20 25 30 Lys Pro Phe Lys Val Thr Val He Gly Ser Gly Asn Trp Gly Thr Thr 35 40 45 He Ala Lys Val Val Ala Glu Asn Cys Lys Gly Tyr Pro Glu Val Phe 50 55 60 Ala Pro He Val Gin Met Trp Val Phe Glu Glu Glu He Asn Gly Glu 65 70 75 80 Lys Leu Thr Glu He He Asn Thr Arg His Gin Asn Val Lys Tyr Leu 85 90 95 Pro Gly He Thr Leu Pro Asp Asn Leu Val Ala Asn Pro Asp Leu He 100 105 110 Asp Ser Val Lys Asp Val Asp He He Val Phe Asn He Pro His Gin 115 120 125 Phe Leu Pro Arg He Cys Ser Gin Leu Lys Gly His Val Asp Ser His 130 135 140 Val Arg Ala He Ser Cys Leu Lys Gly Phe Glu Val Gly Ala Lys Gly 145 150 155 160 Val Gin Leu Leu Ser Ser Tyr He Thr Glu Glu Leu Gly He Gin Cys 165 170 175 Gly Ala Leu Ser Gly Ala Asn He Ala Thr Glu Val Ala Gin Glu His 180 185 190 Trp Ser Glu Thr Thr Val Ala Tyr His He Pro Lys Asp Phe Arg Gly 195 200 205 Glu Gly Lys Asp Val Asp His Lys Val Leu Lys Ala Leu Phe His Arg 210 215 220 Pro Tyr Phe His Val Ser Val He Glu Asp Val Ala Gly He Ser He 225 230 235 240 Cys Gly Ala Leu Lys Asn Val Val Ala Leu Gly Cys Gly Phe Val Glu 245 250 255 Gly Leu Gly Trp Gly Asn Asn Ala Ser Ala Ala He Gin Arg Val Gly 260 265 270 Leu Gly Glu He He Arg Phe Gly Gin Met Phe Phe Pro Glu Ser Arg 275 280 285 Glu Glu Thr Tyr Tyr Gin Glu Ser Ala Gly Val Ala Asp Leu He Thr 290 295 300 Thr Cys Ala Gly Gly Arg Asn Val Lys Val Ala Arg Leu Met Ala Thr 305 310 315 320 Ser Gly Lys Asp Ala Trp Glu Cys Glu Lys Glu Leu Leu Asn Gly Gin 325 330 335 Ser Ala Gin Gly Leu He Thr Cys Lys Glu Val His Glu Trp Leu Glu 340 345 350 Thr Cys Gly Ser Val Glu Asp Phe Pro Leu Phe Glu Ala Val Tyr Gin 355 360 365 He Val Tyr Asn Asn Tyr Pro Met Lys Asn Leu Pro Asp Met He Glu 370 375 380 Glu Leu Asp Leu His Glu Asp 385 390 (2) INFORMATION FOR SEQ ID NO: 8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 384 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8: Met Thr Ala His Thr Asn He Lys Gin His Lys His Cys His Glu Asp 1 5 10 15 His Pro He Arg Arg Ser Asp Ser Ala Val Ser He Val His Leu Lys 20 25 30 Arg Ala Pro Phe Lys Val Thr Val He Gly Ser Gly Asn Trp Gly Thr 35 40 45 Thr He Ala Lys Val He Ala Glu Asn Thr Glu Leu His Ser His He 50 55 60 Phe Glu Pro Glu Val Arg Met Trp Val Phe Asp Glu Lys He Gly Asp 65 70 75 80 Glu Asn Leu Thr Asp He He Asn Thr Arg His G n Asn Val Lys Tyr 85 90 95 Leu Pro Asn He Asp Leu Pro His Asn Leu Val Ala Asp Pro Asp Leu 100 105 110 Leu His Ser He Lys Gly Ala Asp He Leu Val Phe Asn He Pro His 115 120 125 Gin Phe Leu Pro Asn He Val Lys Gin Leu Gin Gly His Val Ala Pro 130 135 140 His Val Arg Ala He Ser Cys Leu Lys Gly Phe Glu Leu Gly Ser Lys 145 150 155 160 Gly Val Gin Leu Leu Ser Ser Tyr Val Thr Asp Glu Leu Gly He Gin 165 170 175 Cys Gly Ala Leu Ser Gly Ala Asn Leu Ala Pro Glu Val Ala Lys Glu 180 185 190 His Trp Ser Glu Thr Thr Val Ala Tyr Gin Leu Pro Lys Asp Tyr Gin 195 200 205 Gly Asp Gly Lys Asp Val Asp His Lys He Leu Lys Leu Leu Phe His 210 215 220 Arg Pro Tyr Phe His Val Asn Val He Asp Asp Val Ala Gly He Ser 225 230 235 240 He Ala Gly Ala Leu Lys Asn Val Val Ala Leu Ala Cys Gly Phe Val 245 250 255 Glu Gly Met Gly Trp Gly Asn Asn Ala Ser Ala Ala He Gin Arg Leu 260 265 270 Gly Leu Gly Glu He He Lys Phe Gly Arg Met Phe Phe Pro Glu Ser 275 280 285 Lys Val Glu Thr Tyr Tyr Gin Glu Ser Ala Gly Val Ala Asp Leu He 290 295 300 Thr Thr Cys Ser Gly Gly Arg Asn Val Lys Val Ala Thr Tyr Met Ala 305 310 315 320 Lys Thr Gly Lys Ser Ala Leu Glu Ala Glu Lys Glu Leu Leu Asn Gly 325 330 335 Gin Ser Ala Gin Gly He He Thr Cys Arg Glu Val His Glu Trp Leu 340 345 350 Gin Thr Cys Glu Leu Thr Gin Glu Phe Pro He He Arg Gly Ser Leu 355 360 365 Pro Asp Ser Leu Gin Gin Arg Pro His Gly Arg Pro Thr Gly Asp Asp 370 375 380 (2) INFORMATION FOR SEQ ID NO: 9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 614 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 9 : Met Thr Arg Ala Thr Trp Cys Asn Ser Pro Pro Pro Leu His Arg Gin 1 5 10 15 Val Ser Arg Arg Asp Leu Leu Asp Arg Leu Asp Lys Thr His Gin Phe 20 25 30 Asp Val Leu He He Gly Gly Gly Ala Thr Gly Thr Gly Cys Ala Leu 35 40 45 Asp Ala Ala Thr Arg Gly Leu Asn Val Ala Leu Val Glu Lys Gly Asp 50 55 60 Phe Ala Ser Gly Thr Ser Ser Lys Ser Thr Lys Met He His Gly Gly 65 70 75 80 Val Arg Tyr Leu Glu Lys Ala Phe Trp Glu Phe Ser Lys Ala Gin Leu 85 90 95 Asp Leu Val He Glu Ala Leu Asn Glu Arg Lys His Leu He Asn Thr 100 105 110 Ala Pro His Leu Cys Thr Val Leu Pro He Leu He Pro He Tyr Ser 115 120 125 Thr Trp Gin Val Pro Tyr He Tyr Met Gly Cys Lys Phe Tyr Asp Phe 130 135 140 Phe Gly Gly Ser Gin Asn Leu Lys Lys Ser Tyr Leu Leu Ser Lys Ser 145 150 155 160 Ala Thr Val Glu Lys Ala Pro Met Leu Thr Thr Asp Asn Leu Lys Ala 165 170 175 Ser Leu Val Tyr His Asp Gly Ser Phe Asn Asp Ser Arg Leu Asn Ala 180 185 190 Thr Leu Ala He Thr Gly Val Glu Asn Gly Ala Thr Val Leu He Tyr 195 200 205 Val Glu Val Gin Lys Leu He Lys Asp Pro Thr Ser Gly Lys Val He 210 215 220 Gly Ala Glu Ala Arg Asp Val Glu Thr Asn Glu Leu Val Arg He Asn 225 230 235 240 Ala Lys Cys Val Val Asn Ala Thr Gly Pro Tyr Ser Asp Ala He Leu 245 250 255 Gin Met Asp Arg Asn Pro Ser Gly Leu Pro Asp Ser Pro Leu Asn Asp 260 265 270 Asn Ser Lys He Lys Ser Thr Phe Asn Gin He Ser Val Met Asp Pro 275 280 285 Lys Met Val He Pro Ser He Gly Val His He Val Leu Pro Ser Phe 290 295 300 Tyr Ser Pro Lys Asp Met Gly Leu Leu Asp Val Arg Thr Ser Asp Gly 305 310 315 320 Arg Val Met Phe Phe Leu Pro Trp Gin Gly Lys Val Leu Ala Gly Thr 325 330 335 Thr Asp He Pro Leu Lys Gin Val Pro Glu Asn Pro Met Pro Thr Glu 340 345 350 Ala Asp He Gin Asp He Leu Lys Glu Leu Gin His Tyr He Glu Phe 355 360 365 Pro Val Lys Arg Glu Asp Val Leu Ser Ala Trp Ala Gly Val Arg Pro 370 375 380 Leu Val Arg Asp Pro Arg Thr He Pro Ala Asp Gly Lys Lys Gly Ser 385 390 395 400 Ala Thr Gin Gly Val Val Arg Ser His Phe Leu Phe Thr Ser Asp Asn 405 410 415 Gly Leu He Thr He Ala Gly Gly Lys Trp Thr Thr Tyr Arg Gin Met 420 425 430 Ala Glu Glu Thr Val Asp Lys Val Val Glu Val Gly Gly Phe His Asn 435 440 445 Leu Lys Pro Cys His Thr Arg Asp He Lys Leu Ala Gly Ala Glu Glu 450 455 460 Trp Thr Gin Asn Tyr Val Ala Leu Leu Ala Gin Asn Tyr His Leu Ser 465 470 475 480 Ser Lys Met Ser Asn Tyr Leu Val Gin Asn Tyr Gly Thr Arg Ser Ser 485 490 495 He He Cys Glu Phe Phe Lys Glu Ser Met Glu Asn Lys Leu Pro Leu 500 505 510 Ser Leu Ala Asp Lys Glu Asn Asn Val He Tyr Ser Ser Glu Glu Asn 515 520 525 Asn Leu Val Asn Phe Asp Thr Phe Arg Tyr Pro Phe Thr He Gly Glu 530 535 540 Leu Lys Tyr Ser Met Gin Tyr Glu Tyr Cys Arg Thr Pro Leu Asp Phe 545 550 555 560 Leu Leu Arg Arg Thr Arg Phe Ala Phe Leu Asp Ala Lys Glu Ala Leu 565 570 575 Asn Ala Val His Ala Thr Val Lys Val Met Gly Asp Glu Phe Asn Trp 580 585 590 Ser Glu Lys Lys Arg Gin Trp Glu Leu Glu Lys Thr Val Asn Phe He 595 600 605 Gin Gly Arg Phe Gly Val 610 (2) INFORMATION FOR SEQ ID NO: 10: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 339 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: Met Asn Gin Arg Asn Ala Ser Met Thr Val He Gly Ala Gly Ser Tyr 1 5 10 15 Gly Thr Ala Leu Ala He Thr Leu Ala Arg Asn Gly His Glu Val Val 20 25 30 Leu Trp Gly His Asp Pro Glu His He Ala Thr Leu Glu Arg Asp Arg 35 40 45 Cys Asn Ala Ala Phe Leu Pro Asp Val Pro Phe Pro Asp Thr Leu His 50 55 60 Leu Glu Ser Asp Leu Ala Thr Ala Leu Ala Ala Ser Arg Asn He Leu 65 70 75 80 Val Val Val Pro Ser His Val Phe Gly Glu Val Leu Arg Gin He Lys 85 90 95 Pro Leu Met Arg Pro Asp Ala Arg Leu Val Trp Ala Thr Lys Gly Leu 100 105 110 Glu Ala Glu Thr Gly Arg Leu Leu Gin Asp Val Ala Arg Glu Ala Leu 115 120 125 Gly Asp Gin He Pro Leu Ala Val He Ser Gly Pro Thr Phe Ala Lys 130 135 140 Glu Leu Ala Ala Gly Leu Pro Thr Ala He Ser Leu Ala Ser Thr Asp 145 150 155 160 Gin Thr Phe Ala Asp Asp Leu Gin Gin Leu Leu His Cys Gly Lys Ser 165 170 175 Phe Arg Val Tyr Ser Asn Pro Asp Phe He Gly Val Gin Leu Gly Gly 180 185 190 Ala Val Lys Asn Val He Ala He Gly Ala Gly Met Ser Asp Gly He 195 200 205 Gly Phe Gly Ala Asn Ala Arg Thr Ala Leu He Thr Arg Gly Leu Ala 210 215 220 Glu Met Ser Arg Leu Gly Ala Ala Leu Gly Ala Asp Pro Ala Thr Phe 225 230 235 240 Met Gly Met Ala Gly Leu Gly Asp Leu Val Leu Thr Cys Thr Asp Asn 245 250 255 Gin Ser Arg Asn Arg Arg Phe Gly Met Met Leu Gly Gin Gly Met Asp 260 265 270 Val Gin Ser Ala Gin Glu Lys He Gly Gin Val Val Glu Gly Tyr Arg 275 280 285 Asn Thr Lys Glu Val Arg Glu Leu Ala His Arg Phe Gly Val Glu Met 290 295 300 Pro He Thr Glu Glu He Tyr Gin Val Leu Tyr Cys Gly Lys Asn Ala 305 310 315 320 Arg Glu Ala Ala Leu Thr Leu Leu Gly Arg Ala Arg Lys Asp Glu Arg 325 330 335 Ser Ser His (2) INFORMATION FOR SEQ ID NO: 11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 501 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11: Met Glu Thr Lys Asp Leu He Val He Gly Gly Gly He Asn Gly Ala 1 5 10 15 Gly He Ala Ala Asp Ala Ala Gly Arg Gly Leu Ser Val Leu Met Leu 20 25 30 Glu Ala Gin Asp Leu Ala Cys Ala Thr Ser Ser Ala Ser Ser Lys Leu 35 40 45 He His Gly Gly Leu Arg Tyr Leu Glu His Tyr Glu Phe Arg Leu Val 50 55 60 Ser Glu Ala Leu Ala Glu Arg Glu Val Leu Leu Lys Met Ala Pro His 65 70 75 80 He Ala Phe Pro Met Arg Phe Arg Leu Pro His Arg Pro His Leu Arg 85 90 95 Pro Ala Trp Met He Arg He Gly Leu Phe Met Tyr Asp His Leu Gly 100 105 110 Lys Arg Thr Ser Leu Pro Gly Ser Thr Gly Leu Arg Phe Gly Ala Asn 115 120 125 Ser Val Leu Lys Pro Glu He Lys Arg Gly Phe Glu Tyr Ser Asp Cys 130 135 140 Trp Val Asp Asp Ala Arg Leu Val Leu Ala Asn Ala Gin Met Val Val 145 150 155 160 Arg Lys Gly Gly Glu Val Leu Thr Arg Thr Arg Ala Thr Ser Ala Arg 165 170 175 Arg Glu Asn Gly Leu Trp He Val Glu Ala Glu Asp He Asp Thr Gly 180 185 190 Lys Lys Tyr Ser Trp Gin Ala Arg Gly Leu Val Asn Ala Thr Gly Pro 195 200 205 Trp Val Lys Gin Phe Phe Asp Asp Gly Met His Leu Pro Ser Pro Tyr 210 215 220 Gly He Arg Leu He Lys Gly Ser His He Val Val Pro Arg Val His 225 230 235 240 Thr Gin Lys Gin Ala Tyr He Leu Gin Asn Glu Asp Lys Arg He Val 245 250 255 Phe Val He Pro Trp Met Asp Glu Phe Ser He He Gly Thr Thr Asp 260 265 270 Val Glu Tyr Lys Gly Asp Pro Lys Ala Val Lys He Glu Glu Ser Glu 275 280 285 He Asn Tyr Leu Leu Asn Val Tyr Asn Thr His Phe Lys Lys Gin Leu 290 295 300 Ser Arg Asp Asp He Val Trp Thr Tyr Ser Gly Val Arg Pro Leu Cys 305 310 315 320 Asp Asp Glu Ser Asp Ser Pro Gin Ala He Thr Arg Asp Tyr Thr Leu 325 330 335 Asp He His Asp Glu Asn Gly Lys Ala Pro Leu Leu Ser Val Phe Gly 340 345 350 Gly Lys Leu Thr Thr Tyr Arg Lys Leu Ala Glu His Ala Leu Glu Lys 355 360 365 Leu Thr Pro Tyr Tyr Gin Gly He Gly Pro Ala Trp Thr Lys Glu Ser 370 375 380 Val Leu Pro Gly Gly Ala He Glu Gly Asp Arg Asp Asp Tyr Ala Ala 385 390 395 400 Arg Leu Arg Arg Arg Tyr Pro Phe Leu Thr Glu Ser Leu Ala Arg His 405 410 415 Tyr Ala Arg Thr Tyr Gly Ser Asn Ser Glu Leu Leu Leu Gly Asn Ala 420 425 430 Gly Thr Val Ser Asp Leu Gly Glu Asp Phe Gly His Glu Phe Tyr Glu 435 440 445 Ala Glu Leu Lys Tyr Leu Val Asp His Glu Trp Val Arg Arg Ala Asp 450 455 460 Asp Ala Leu Trp Arg Arg Thr Lys Gin Gly Met Trp Leu Asn Ala Asp 465 470 475 480 Gin Gin Ser Arg Val Ser Gin Trp Leu Val Glu Tyr Thr Gin Gin Arg 485 490 495 Leu Ser Leu Ala Ser 500 (2) INFORMATION FOR SEQ ID NO: 12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 542 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: Met Lys Thr Arg Asp Ser Gin Ser Ser Asp Val He He He Gly Gly 1 5 10 15 Gly Ala Thr Gly Ala Gly He Ala Arg Asp Cys Ala Leu Arg Gly Leu 20 25 30 Arg Val He Leu Val Glu Arg His Asp He Ala Thr Gly Ala Thr Gly 35 40 45 Arg Asn His Gly Leu Leu His Ser Gly Ala Arg Tyr Ala Val Thr Asp 50 55 60 Ala Glu Ser Ala Arg Glu Cys He Ser Glu Asn Gin He Leu Lys Arg 65 70 75 80 He Ala Arg His Cys Val Glu Pro Thr Asn Gly Leu Phe He Thr Leu 85 90 95 Pro Glu Asp Asp Leu Ser Phe Gin Ala Thr Phe He Arg Ala Cys Glu 100 105 110 Glu Ala Gly He Ser Ala Glu Ala He Asp Pro Gin Gin Ala Arg He 115 120 125 He Glu Pro Ala Val Asn Pro Ala Leu He Gly Ala Val Lys Val Pro 130 135 140 Asp Gly Thr Val Asp Pro Phe Arg Leu Thr Ala Ala Asn Met Leu Asp 145 150 155 160 Ala Lys Glu His Gly Ala Val He Leu Thr Ala His Glu Val Thr Gly 165 170 175 Leu He Arg Glu Gly Ala Thr Val Cys Gly Val Arg Val Arg Asn His 180 185 190 Leu Thr Gly Glu Thr Gin Ala Leu His Ala Pro Val Val Val Asn Ala 195 200 205 Ala Gly He Trp Gly Gin His He Ala Glu Tyr Ala Asp Leu Arg He 210 215 220 Arg Met Phe Pro Ala Lys Gly Ser Leu Leu He Met Asp His Arg He 225 230 235 240 Asn Gin His Val He Asn Arg Cys Arg Lys Pro Ser Asp Ala Asp He 245 250 255 Leu Val Pro Gly Asp Thr He Ser Leu He Gly Thr Thr Ser Leu Arg 260 265 270 He Asp Tyr Asn Glu He Asp Asp Asn Arg Val Thr Ala Glu Glu Val 275 280 285 Asp He Leu Leu Arg Glu Gly Glu Lys Leu Ala Pro Val Met Ala Lys 290 295 300 Thr Arg He Leu Arg Ala Tyr Ser Gly Val Arg Pro Leu Val Ala Ser 305 310 315 320 Asp Asp Asp Pro Ser Gly Arg Asn Leu Ser Arg Gly He Val Leu Leu 325 330 335 Asp His Ala Glu Arg Asp Gly Leu Asp Gly Phe He Thr He Thr Gly 340 345 350 Gly Lys Leu Met Thr Tyr Arg Leu Met Ala Glu Trp Ala Thr Asp Ala 355 360 365 Val Cys Arg Lys Leu Gly Asn Thr Arg Pro Cys Thr Thr Ala Asp Leu 370 375 380 Ala Leu Pro Gly Ser Gin Glu Pro Ala Glu Val Thr Leu Arg Lys Val 385 390 395 400 He Ser Leu Pro Ala Pro Leu Arg Gly Ser Ala Val Tyr Arg His Gly 405 410 415 Asp Arg Thr Pro Ala Trp Leu Ser Glu Gly Arg Leu His Arg Ser Leu 420 425 430 Val Cys Glu Cys Glu Ala Val Thr Ala Gly Glu Val Gin Tyr Ala Val 435 440 445 Glu Asn Leu Asn Val Asn Ser Leu Leu Asp Leu Arg Arg Arg Thr Arg 450 455 460 Val Gly Met Gly Thr Cys Gin Gly Glu Leu Cys Ala Cys Arg Ala Ala 465 470 475 480 Gly Leu Leu Gin Arg Phe Asn Val Thr Thr Ser Ala Gin Ser He Glu 485 490 495 Gin Leu Ser Thr Phe Leu Asn Glu Arg Trp Lys Gly Val Gin Pro He 500 505 510 Ala Trp Gly Asp Ala Leu Arg Glu Ser Glu Phe Thr Arg Trp Val Tyr 515 520 525 Gin Gly Leu Cys Gly Leu Glu Lys Glu Gin Lys Asp Ala Leu 530 535 540 (2) INFORMATION FOR SEQ ID NO: 13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 250 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: Met Gly Leu Thr Thr Lys Pro Leu Ser Leu Lys Val Asn Ala Ala Leu 1 5 10 15 Phe Asp Val Asp Gly Thr He He He Ser Gin Pro Ala He Ala Ala 20 25 30 Phe Trp Arg Asp Phe Gly Lys Asp Lys Pro Tyr Phe Asp Ala Glu His 35 40 45 Val He Gin Val Ser His Gly Trp Arg Thr Phe Asp Ala He Ala Lys 50 55 60 Phe Ala Pro Asp Phe Ala Asn Glu Glu Tyr Val Asn Lys Leu Glu Ala 65 70 75 80 Glu He Pro Val Lys Tyr Gly Glu Lys Ser He Glu Val Pro Gly Ala 85 90 95 Val Lys Leu Cys Asn Ala Leu Asn Ala Leu Pro Lys Glu Lys Trp Ala 100 105 110 Val Ala Thr Ser Gly Thr Arg Asp Met Ala Gin Lys Trp Phe Glu His 115 120 125 Leu Gly He Arg Arg Pro Lys Tyr Phe He Thr Ala Asn Asp Val Lys 130 135 140 Gin Gly Lys Pro His Pro Glu Pro Tyr Leu Lys Gly Arg Asn Gly Leu 145 150 155 160 Gly Tyr Pro He Asn Glu Gin Asp Pro Ser Lys Ser Lys Val Val Val 165 170 175 Phe Glu Asp Ala Pro Ala Gly He Ala Ala Gly Lys Ala Ala Gly Cys 180 185 190 Lys He He Gly He Ala Thr Thr Phe Asp Leu Asp Phe Leu Lys Glu 195 200 205 Lys Gly Cys Asp He He Val Lys Asn His Glu Ser He Arg Val Gly 210 215 220 Gly Tyr Asn Ala Glu Thr Asp Glu Val Glu Phe He Phe Asp Asp Tyr 225 230 235 240 Leu Tyr Ala Lys Asp Asp Leu Leu Lys Trp 245 250 (2) INFORMATION FOR SEQ ID NO: 14: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 271 ammo acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (n) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14: Met Lys Arg Phe Asn Val Leu Lys Tyr He Arg Thr Thr Lys Ala Asn 1 5 10 15 He Gin Thr He Ala Met Pro Leu Thr Thr Lys Pro Leu Ser Leu Lys 20 25 30 He Asn Ala Ala Leu Phe Asp Val Asp Gly Thr He He He Ser Gin 35 40 45 Pro Ala He Ala Ala Phe Trp Arg Asp Phe Gly Lys Asp Lys Pro Tyr 50 55 60 Phe Asp Ala Glu His Val He His He Ser His Gly Trp Arg Thr Tyr 65 70 75 80 Asp Ala He Ala Lys Phe Ala Pro Asp Phe Ala Asp Glu Glu Tyr Val 85 90 95 Asn Lys Leu Glu Gly Glu He Pro Glu Lys Tyr Gly Glu His Ser He 100 105 110 Glu Val Pro Gly Ala Val Lys Leu Cys Asn Ala Leu Asn Ala Leu Pro 115 120 125 Lys Glu Lys Trp Ala Val Ala Thr Ser Gly Thr Arg Asp Met Ala Lys 130 135 140 Lys Trp Phe Asp He Leu Lys He Lys Arg Pro Glu Tyr Phe He Thr 145 150 155 160 Ala Asn Asp Val Lys Gin Gly Lys Pro His Pro Glu Pro Tyr Leu Lys 165 170 175 Gly Arg Asn Gly Leu Gly Phe Pro He Asn Glu Gin Asp Pro Ser Lys 180 185 190 Ser Lys Val Val Val Phe Glu Asp Ala Pro Ala Gly He Ala Ala Gly 195 200 205 Lys Ala Ala Gly Cys Lys He Val Gly He Ala Thr Thr Phe Asp Leu 210 215 220 Asp Phe Leu Lys Glu Lys Gly Cys Asp He He Val Lys Asn His Glu 225 230 235 240 Ser He Arg Val Gly Glu Tyr Asn Ala Glu Thr Asp Glu Val Glu Leu 245 250 255 He Phe Asp Asp Tyr Leu Tyr Ala Lys Asp Asp Leu Leu Lys Trp 260 265 270 (2) INFORMATION FOR SEQ ID NO: 15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 709 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15: Met Phe Pro Ser Leu Phe Arg Leu Val Val Phe Ser Lys Arg Tyr He 1 5 10 15 Phe Arg Ser Ser Gin Arg Leu Tyr Thr Ser Leu Lys Gin Glu Gin Ser 20 25 30 Arg Met Ser Lys He Met Glu Asp Leu Arg Ser Asp Tyr Val Pro Leu 35 40 45 He Ala Ser He Asp Val Gly Thr Thr Ser Ser Arg Cys He Leu Phe 50 55 60 Asn Arg Trp Gly Gin Asp Val Ser Lys His Gin He Glu Tyr Ser Thr 65 70 75 80 Ser Ala Ser Lys Gly Lys He Gly Val Ser Gly Leu Arg Arg Pro Ser 85 90 95 Thr Ala Pro Ala Arg Glu Thr Pro Asn Ala Gly Asp He Lys Thr Ser 100 105 110 Gly Lys Pro He Phe Ser Ala Glu Gly Tyr Ala He Gin Glu Thr Lys 115 120 125 Phe Leu Lys He Glu Glu Leu Asp Leu Asp Phe His Asn Glu Pro Thr 130 135 140 Leu Lys Phe Pro Lys Pro Gly Trp Val Glu Cys His Pro Gin Lys Leu 145 150 155 160 Leu Val Asn Val Val Gin Cys Leu Ala Ser Ser Leu Leu Ser Leu Gin 165 170 175 Thr He Asn Ser Glu Arg Val Ala Asn Gly Leu Pro Pro Tyr Lys Val 180 185 190 He Cys Met Gly He Ala Asn Met Arg Glu Thr Thr He Leu Trp Ser 195 200 205 Arg Arg Thr Gly Lys Pro He Val Asn Tyr Gly He Val Trp Asn Asp 210 215 220 Thr Arg Thr He Lys He Val Arg Asp Lys Trp Gin Asn Thr Ser Val 225 230 235 240 Asp Arg Gin Leu Gin Leu Arg Gin Lys Thr Gly Leu Pro Leu Leu Ser 245 250 255 Thr Tyr Phe Ser Cys Ser Lys Leu Arg Trp Phe Leu Asp Asn Glu Pro 260 265 270 Leu Cys Thr Lys Ala Tyr Glu Glu Asn Asp Leu Met Phe Gly Thr Val 275 280 285 Asp Thr Trp Leu He Tyr Gin Leu Thr Lys Gin Lys Ala Phe Val Ser 290 295 300 Asp Val Thr Asn Ala Ser Arg Thr Gly Phe Met Asn Leu Ser Thr Leu 305 310 315 320 Lys Tyr Asp Asn Glu Leu Leu Glu Phe Trp Gly He Asp Lys Asn Leu 325 330 335 He His Met Pro Glu He Val Ser Ser Ser Gin Tyr Tyr Gly Asp Phe 340 345 350 Gly He Pro Asp Trp He Met Glu Lys Leu His Asp Ser Pro Lys Thr 355 360 365 Val Leu Arg Asp Leu Val Lys Arg Asn Leu Pro He Gin Gly Cys Leu 370 375 380 Gly Asp Gin Ser Ala Ser Met Val Gly Gin Leu Ala Tyr Lys Pro Gly 385 390 395 400 Ala Ala Lys Cys Thr Tyr Gly Thr Gly Cys Phe Leu Leu Tyr Asn Thr 405 410 415 Gly Thr Lys Lys Leu He Ser Gin His Gly Ala Leu Thr Thr Leu Ala 420 425 430 Phe Trp Phe Pro His Leu Gin Glu Tyr Gly Gly Gin Lys Pro Glu Leu 435 440 445 Ser Lys Pro His Phe Ala Leu Glu Gly Ser Val Ala Val Ala Gly Ala 450 455 460 Val Val Gin Trp Leu Arg Asp Asn Leu Arg Leu He Asp Lys Ser Glu 465 470 475 480 Asp Val Gly Pro He Ala Ser Thr Val Pro Asp Ser Gly Gly Val Val 485 490 495 Phe Val Pro Ala Phe Ser Gly Leu Phe Ala Pro Tyr Trp Asp Pro Asp 500 505 510 Ala Arg Ala Thr He Met Gly Met Ser Gin Phe Thr Thr Ala Ser His 515 520 525 He Ala Arg Ala Ala Val Glu Gly Val Cys Phe Gin Ala Arg Ala He 530 535 540 Leu Lys Ala Met Ser Ser Asp Ala Phe Gly Glu Gly Ser Lys Asp Arg 545 550 555 560 Asp Phe Leu Glu Glu He Ser Asp Val Thr Tyr Glu Lys Ser Pro Leu 565 570 575 Ser Val Leu Ala Val Asp Gly Gly Met Ser Arg Ser Asn Glu Val Met 580 585 590 Gin He Gin Ala Asp He Leu Gly Pro Cys Val Lys Val Arg Arg Ser 595 600 605 Pro Thr Ala Glu Cys Thr Ala Leu Gly Ala Ala He Ala Ala Asn Met 610 615 620 Ala Phe Lys Asp Val Asn Glu Arg Pro Leu Trp Lys Asp Leu His Asp 625 630 635 640 Val Lys Lys Trp Val Phe Tyr Asn Gly Met Glu Lys Asn Glu Gin He 645 650 655 Ser Pro Glu Ala His Pro Asn Leu Lys He Phe Arg Ser Glu Ser Asp 660 665 670 Asp Ala Glu Arg Arg Lys His Trp Lys Tyr Trp Glu Val Ala Val Glu 675 680 685 Arg Ser Lys Gly Trp Leu Lys Asp He Glu Gly Glu His Glu Gin Val 690 695 700 Leu Glu Asn Phe Gin 705 (2) INFORMATION FOR SEQ ID NO: 16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 51 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16: GCGCGGATCC AGGAGTCTAG AATTATGGGA TTGACTACTA AACCTCTATC T 51 (2) INFORMATION FOR SEQ ID NO: 17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 36 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: GATACGCCCG GGTTACCATT TCAACAGATC GTCCTT 36 (2) INFORMATION FOR SEQ ID NO: 18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 34 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18: TTGATAATAT AACCATGGCT GCTGCTGCTG ATAG 34 (2) INFORMATION FOR SEQ ID NO: 19: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 39 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19: GTATGATATG TTATCTTGGA TCCAATAAAT CTAATCTTC 39 (2) INFORMATION FOR SEQ ID NO: 20: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 20: CATGACTAGT AAGGAGGACA ATTC 24 (2) INFORMATION FOR SEQ ID NO: 21: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21: CATGGAATTG TCCTCCTTAC TAGT 24 (2) INFORMATION FOR SEQ ID NO: 22: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 19 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22: CTAGTAAGGA GGACAATTC 19 (2) INFORMATION FOR SEQ ID NO:23: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 19 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 23: CATGGAATTG TCCTCCTTA 19 (2) INFORMATION FOR SEQ ID NO:24: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "PRIMER" (m) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 24: GATCCAGGAA ACAGA 15 (2) INFORMATION FOR SEQ ID NO: 25: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "PRIMER" (ill) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 25: CTAGTCTGTT TCCTG 15 INDICATIONS RELATING TO A DEPOSITED MICROORGANISM (PCT Rule \ 3bis) A. The indications made below relate to the microorganism referred to in the description on page 3 , line s 21 and 22 B. IDENTIFICATION OF DEPOSIT Further deposits are identified on an additional sheet I I Name of depositary institution AMERICAN TYPE CULTURE COLLECTION Address of depositary institution (including postal code and country) 12301 Parklawn Drive Rockville , Maryland 20852 US Date of deposit Accession Number 26 September 1996 98187 C. ADDITIONAL INDICATIONS (leave blank if not applicable) This information is continued on an additional sheet [~] In respect of those designations in which a European patent is sought, a sample of the deposited microorganism will be made available until the publication of the mention of the grant of the European patent or until the-date on which the application has been refused or withdrawn or is deemed to be withdrawn, only by the issue of such a sample to an expert nominated by the person requesting the sample. (Rule 28(4) EPC) D. DESIGNATED STATES FOR WHICH INDICATIONS ARE MADE (if the indications are not for all designated States) E. SEPARATE FURNISHING OF INDICATIONS (leave blank if not applicable) The indications listed below will be submitted to the International Bureau later (specify the general nature oj the indications e g , "Accession Number of Deposit") For receiving Office use only For International Bureau use only j j Tins sheet was received with the international application I I This sheet was received by the International Bureau on' Authorized officer Authorized officer Form PCT RO/134 (July 1992) INDICATIONS RELATING TO A DEPOSITED MICROORGANISM (PCT Rule \3bis) A. The indications made below relate to the microorganism referred to in the description on page 3 . lines 21 and 27. B. IDENTIFICATION OF DEPOSIT Further deposits are identified on an additional sheet I I Name of depositary institution AMERICAN TYPE CULTURE COLLECTION Address of depositary institution (including postal code and country) 12301 Parklawn Drive Rockville , Maryland 20852 US Dale of deposit Accession Number 06 November 1996 98248 C. ADDITIONAL INDICATIONS (leave blank if not applicable) This information is continued on an additional sheet [~_~J In respect of those designations in which a European patent is sought, a sample of the deposited microorganism will be made available until the publication of the mention of the grant of the European patent or until the" date on which the application has been refused or withdrawn or is deemed to be withdrawn, only by the issue of such a sample to an expert nominated by the person requesting the sample. (Rule 28(4) EPC) D. DESIGNATED STATES FOR WHICH INDICATIONS ARE MADE (if the indications are not for all designated Slates) E. SEPARATE FURNISHING OF INDICATIONS (leave blank if not applicable) The indications listed below will be submitted to the International Bureau later (specify the general nature of the indications e g , "Accession Number of Deposit") For receiving Office use only For International Bureau use only [ j This sheet was received with the international application j I This sheet was received by the International Bureau on Authorized officer Authorized officer Form PCT RO/134 (July 1992)

Claims: WHAT IS CLAIMED IS: 1. A method for the production of glycerol from a recombinant organism comprising: (i) transforming a suitable host cell with an expression cassette comprising either one or both of (a) a gene encoding a glycerol-3 -phosphate dehydrogenase enzyme; (b) a gene encoding a glycerol-3 -phosphate phosphatase enzyme; (ii) culturing the transformed host cell of (i) in the presence of at least one carbon source selected from the group consisting of monosaccharides, oligosaccharides, polysaccharides, and single-carbon substrates, whereby glycerol is produced; and (iii) recovering the glycerol produced in (ii). 2. A method according to Claim 1 wherein the expression cassette comprises a gene encoding a glycerol-3-phosphate dehydrogenase activity. 3. A method according to Claim 1 wherein said expression cassette comprises a gene encoding a glycerol-3 -phosphate phosphatase activity. 4. A method according to Claim 1 wherein said expression cassette comprising gene encoding a glycerol-3 -phosphate phosphatase activity and a glycerol-3 -phosphate dehydrogenase activity. 5. A method according to Claim 1 wherein the suitable host cell is selected from the group consisting of bacteria, yeast, and filamentous fungi. 6. A method according to Claim 5 wherein the suitable host cell is selected from the group consisting of Citrobader, Enterobader, Clostridium, Klebsiella, Aerobader, Ladobacillus, Aspergillus, Saccharomyces, Schizosaccharomyces, Zygosaccharomyces, Pichia, Kluyveromyces, Candida, Hansenula, Debaryomyces, Mucor, Torulopsis, Methylobacter, Escherichia, Salmonella, Bacillus, Streptomyces, and Pseudomonas. 7. A method according to Claim 6 wherein the suitable host cell is E. coli or Saccharomyces. 8. A method according to Claim 1 wherein the carbon source is glucose. 9. A method according to Claim 1 wherein the gene encoding a glycerol-3 -phosphate dehydrogenase enzyme corresponds to the amino acid sequence given in SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO10, SEQ ID NO:l 1, or SEQ ID NO: 12 and wherein the amino acid sequence encompasses amino acid substitutions, deletions or insertions that do not alter the functional properties ofthe enzyme. 10. A method according to Claim 1 wherein the gene encoding a glycerol-3 -phosphatase enzyme corresponds to the amino acid sequence given in SEQ ID NO: 13 or SEQ ID NO: 14 and wherein the amino acid sequence may encompass amino acid substitutions, deletions or additions that do not alter the function of the enzyme. 11. A method according to Claim 1 wherein the gene encoding a glycerol kinase enzyme corresponds to the amino acid sequence given in SEQ ID NO: 15 and wherein said amino acid sequence may encompass amino acid substitutions, deletions or additions that do not alter the function of said enzyme. 12. A transformed host cell comprising a gene encoding a glycerol-3 - phosphate dehydrogenase activity. 13. A transformed host cell comprising a gene encoding a glycerol-3 - phosphate phosphatase activity. 14. A method for selecting for glycerol-3 -phosphate dehydrogenase gene expression by complementation comprising supplying glycerol or glycerol-3 - phosphate to a strain auxotrophic for glycerol or glycerol-3 -phosphate by virtue of a mutation in glycerol-3 -phosphate dehydrogenase gene ofthe strain. 15. A method for selecting for glycerol-3 -phosphate dehydrogenase gene expression by complementation comprising supplying salt to a strain osmosensitive by virtue of a mutation in gene for glycerol-3-phosphate dehydrogenase ofthe strain. 16. An Escherichia coli pAH21/DH5α containing the GPP2 gene and identified by the designation ATCC 98187. 17. An Escherichia coli pDARl A/AA200 containing the DARl gene and identified by the designation ATCC 98248.

Inventors: BULTHUIS BEN A, GATENBY ANTHONY ARTHUR, HAYNIE SHARON LORETTA, HSU AMY KUANG-HUA, LAREAU RICHARD D, BULTHUIS, BEN, A., GATENBY, ANTHONY, ARTHUR, HAYNIE, SHARON, LORETTA, HSU, AMY, KUANG-HUA, LAREAU, RICHARD, D.
Applicants: BULTHUIS BEN A, DU PONT, GATENBY ANTHONY ARTHUR, GENENCOR INT, HAYNIE SHARON LORETTA, HSU AMY KUANG HUA, LAREAU RICHARD D, BULTHUIS, BEN, A., E.I. DU PONT DE NEMOURS AND COMPANY, GATENBY, ANTHONY, ARTHUR, GENENCOR INTERNATIONAL, INC., HAYNIE, SHARON, LORETTA, HSU, AMY, KUANG-HUA, LAREAU, RICHARD, D.
Application year: 1997
Main classification: C12N15
IPC codes: C12N1, C12N5, C12N9, C12N15, C12P7